Member list of California Life Sciences Association

Below you find a list of all members of CLSA in alphabetical order.

Results 1 - 300 out of 300 displayed.
 
Sort direction:
Sort direction:
4baseCare   
Bengaluru, India
4baseCare is an Illumina Accelerator company focused on developing precision oncology solutions that integrate advanced genomics, AI, and real-world clinical data to support personalized cancer care. The company has built a patient-centric oncology ecosystem that combines genomic and clinico-genomic data with treatment and clinical outcomes to support evidence-based treatment decisions, biomarker discovery, clinical research, and drug development. The company offers comprehensive genomic profiling...
712 North Inc.   
Berkeley, USA
712 North Inc. is a preclinical biotechnology company developing personalized mitochondrial medicines for age-related diseases. The company targets the mitochondrial stress response, particularly the OMA1/OPA1 pathway, to develop therapies for diseases including cancer, neurodegenerative disorders, and cardiovascular diseases.
Abalone Bio   
Emeryville, USA
Abalone Bio is a preclinical-stage biotechnology company developing antibody therapeutics targeting GPCRs, ion channels and other membrane proteins. The company uses its proprietary Functional Antibody Selection Technology (FAST) platform, which combines high-throughput functional antibody screening and machine learning to discover and design antibodies that activate or modulate challenging biological targets. Its pipeline includes programs in metabolic diseases, inflammation, pain and cancer.
Abiosciences   
South San Francisco, USA
Abiosciences is a biotechnology and single-cell genomics company focused on translational research, drug discovery and precision medicine. The company develops single-cell and spatial omics platforms, disease-specific cellular databases, and data analytics technologies to understand disease mechanisms at the cellular level. Its platforms are designed to identify and validate novel therapeutic targets and biomarkers, helping pharmaceutical and biotechnology companies accelerate the development...
Abterra Biosciences, Inc.   
San Diego, USA
Abterra Biosciences is a biotechnology company providing antibody sequencing and discovery technologies and services. The company combines next-generation sequencing, mass spectrometry, proteomics, bioinformatics, and machine learning to characterize antibody responses and support the discovery, sequencing, and analysis of antibodies for therapeutic research and development.
Accelero Biostructures   
San Francisco, USA
Accelero Biostructures has been providing state-of-the-art, high-throughput protein X-ray crystallography-driven drug discovery and structural biology solutions to pharmaceutical/biotechnology companies using its ABS-ServicesTM and ABS-OneStepTM platforms. ABS-Services provides a unified pipeline of protein X-ray crystallography solutions aimed at the pharmaceutical and biotechnology industries to support structure-based drug discovery and protein engineering. ABS-OneStep is the next-generation...
Accunome Sciences, Inc.   
San Diego, USA
Accunome Sciences, a Delaware company, is a startup company building ultra-sensitive molecular diagnostic tests for infectious respiratory diseases.
Acepodia Inc.   
Alameda, USA
Acepodia is a clinical-stage biotechnology company developing cell therapies using its Antibody-Cell Conjugation (ACC) and allogeneic gamma delta 2 (γδ2) T cell platforms. ACE1831 is an off-the-shelf γδ2 T cell therapy candidate developed using Acepodia's ACC platform. It is designed to target CD20-expressing hematological cancers through anti-CD20 antibody-conjugated γδ2 T cells. ACE2016 is an off-the-shelf γδ2 T cell therapy candidate developed using Acepodia's ACC platform. It...
Achelois BioPharma, Inc.   
Redwood City, USA
Achelois BioPharma is building a portfolio of bespoke T-cell therapies for advanced solid tumors and hematologic malignancies, progressing through IIT and Phase I development.
ActiveSite Pharmaceuticals, Inc.   
Berkeley, USA
ActiveSite Pharmaceuticals utilizes the discovery technology to discover new small molecule drug candidates for human diseases with unmet medical need. The company is focused on developing treatments for the vision-threatening complication of diabetes, diabetic macular edema, and the genetic disease hereditary angioedema, by targeting the vascular protease plasma kallikrein.
Actym Therapeutics, Inc.   
Berkeley, USA
Actym Therapeutics, Inc. is a biotechnology company focused on the discovery and development of transformational immunotherapies to treat cancer. The company has developed an avirulent, programmable, live immunotherapeutic modality called STACT (S. Typhimurium-Attenuated Cancer Therapy). Actym’s lead candidate, ACTM-838 leverages these capabilities and is being tested as a single agent and in combination with anti-PD1 therapy across multiple solid tumor types.
Adcentrx Therapeutics   
San Diego, USA
Adcentrx Therapeutics is a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases. The company's product ADRX-0405 is a clinical-stage next-generation ADC targeting six-transmembrane epithelial antigen of the prostate 1 (STEAP1), a cell surface protein that is upregulated in prostate cancer and certain other cancers with limited expression in normal healthy tissue.
ADS Biosystems Inc.   
San Diego, USA
ADS Biosystems Inc. focuses on cancer and metabolic diseases. The company has established state-of-the-art platforms for early cancer detection with new cancer markers. ADS has also been working on potential therapeutics against SARS-CoV-2. The company's quantitative ELISA kit detects RBD binding antibodies against the RBD domain of the spike protein of SARS-CoV-2 and has been verified with 31 recovered COVID-19 patients and healthy controls.
Advanced Microbubbles Inc   
Newark, USA
Advanced Microbubbles Inc. develops monodisperse, size-isolated microbubbles (SIMBs) that enhance contrast-enhanced ultrasound (CEUS) imaging and act as an ultrasound-triggered drug delivery platform. The technology enables noninvasive blood-brain barrier opening and targeted cancer therapy, significantly boosting drug uptake while minimizing systemic toxicity.
AEGEA Biotechnologies, Inc.   
Poway, USA
Aegea Biotechnologies is a biotechnology company developing a series of reagents, research kits, and in-vitro diagnostic (IVD) products for molecular analysis based on proprietary nucleic acid chemistries and methodologies. The company offers custom solutions, including assay development and adaptation of its technologies for different platforms, to various types of businesses, including pharmaceutical and biotech companies, diagnostics companies, DNA sequencing companies, and others.
AesculaTech   
Los Angeles, USA
AesculaTech is a medtech company that uses a new class of smart materials to develop biomedical and consumer products. The company's proprietary platform is engineered to change properties in response to temperature and other stimuli. The company's first product is a one-size-fits-all punctal plug for the treatment for dry eye disease (DED) called Humidifeye, a kind of autoinjector that delivers a proprietary gel to the tear duct for reliable treatment.
Agragene, Inc.   
Saint Louis, USA
Agragene is focused on commercializing insect control solutions with its proprietary gene editing technology. The company's Precision-Guided Sterile Insect Technology™ (pgSIT)™ is a CRISPR gene editing-powered platform that effectively eliminates insect pest procreation of specially targeted invasive and challenging insect pests without the use of chemicals or radiation. The company's products are sold under the KNOCKOUT™ brand.
Alamar Biosciences, Inc.   
Fremont, USA
Alamar Biosciences is a life sciences company with a mission to transform the field of proteomics to enable the early detection of cancer and other diseases. The company’s two proprietary technology platforms, NULISA™ and Attobody™, work seamlessly with the latest advances in genomics to achieve single-digit attomolar detection sensitivity, greatly surpassing the most sensitive protein detection technology on the market today
Alector, Inc.   
South San Francisco, USA
Alector is a clinical-stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. The company utilizes a proprietary Alector Brain Carrier (ABC) technology platform, designed to improve blood-brain barrier transport and enhance therapeutic delivery. Alector, Inc. specializes in developing immuno-neurology therapies to treat or prevent neurodegenerative diseases, such as Alzheimer's, Parkinson's, and frontotemporal dementia....
Algen Biotechnologies, Inc.   
San Francisco, USA
Algen is a provider of therapeutic solutions for drug discovery. The company offers a therapeutic discovery company building a platform to decode functional gene networks for drug discovery. The company offers technologies and science to dissect complex disease signaling and gene networks to target identification and validation, enabling drug companies to decode functional gene networks for drug discovery.
Aligos Therapeutics, Inc.   
South San Francisco, USA
Aligos Therapeutics, Inc. is a clinical-stage biotechnology company founded with the mission to improve patient outcomes by developing best-in-class therapies for the treatment of liver and viral diseases. Aligos applies its science-driven approach and deep R&D expertise to advance its purpose-built pipeline of therapeutics for high unmet medical needs, including chronic hepatitis B virus infection, metabolic dysfunction-associated steatohepatitis (MASH), and coronaviruses.
Alpine Bio   
South San Francisco, USA
Alpine Bio is a developer of a plant genetics company intended to transform plants into efficient protein factories. The company offers proteins and bioactives characterized by high solubility, neutral flavor, and clean-label performance, utilizing pioneering forms of biomanufacturing to create hyper-functional components that remain invisible in final formulations, enabling food and beverage formulators to improve product quality without compromising on taste or sustainability.
Altay Therapeutics   
San Carlos, USA
Altay Therapeutics is a biotechnology company developing small-molecule inhibitors targeting transcription factors involved in disease. The company's lead drug candidate, DX5057, is an investigational oral inhibitor of DUX4 being developed for facioscapulohumeral muscular dystrophy (FSHD). The company’s discovery platform uses AI-based modelling, computational analysis, and in silico docking to identify allosteric binding sites on transcription factors and support the design of small-molecule...
Alveo Technologies, Inc.   
Alameda, USA
Alveo Technologies is a diagnostics company that develops innovative technology platforms for disease detection and personal care, focusing on sensing, microfluidics, and bioassays. The company's cloud-based diagnostic solutions enable the creation of vast datasets to track infectious disease outbreaks and connect individuals with treatments. Alveo's technology aims to empower consumers, healthcare professionals, and treatment providers to detect and manage diseases that threaten public health.
Amydis, Inc.   
Los Angeles, USA
Amydis, Inc. is a privately-held, clinical-stage biotechnology company developing novel, proprietary ocular-tracer molecules designed to bind and fluoresce when attached to disease-associated protein aggregates (such as amyloid-β, tau, alpha-synuclein, TDP-43) enabling non-invasive detection of molecular biomarkers in the retina with standard eye-imaging devices. The company's lead candidate AMDX-2011Pis a small-molecule, non-radioactive imaging agent designed to bind to protein aggregates...
Anchor Molecular   
Pleasanton, USA
Anchor Molecular is a life science diagnostics company specializing in the development of controls, reference materials, and reagents for liquid biopsy assays. The company is focused on liquid biopsy cancer diagnostic test based on cell-free DNA (cfDNA) and circulating tumor DNA (ctDNA).
Ansa Biotechnologies, Inc.   
Emeryville, USA
Ansa Biotechnologies, Inc. have developed a process for enzymatic DNA synthesis in which terminal deoxynucleotidyl transferases (TdT) are covalently linked to nucleotides with a photocleavable linker. The company's enzyme-based approach dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing. The company's enzymatic DNA synthesis technology is based on TdT-dNTP conjugates, enzymatic reagents that enable rapid and controlled...
Anwita Biosciences   
San Carlos, USA
Anwita Biosciences is a startup company specializing in antibodies and fusion proteins for therapies in oncology and auto-immune disease. The company is developing tissue-specific drug delivery to improve their therapeutic indices. Anwita develops ex-vivo disease models using tissue and cancer organoids to more efficiently screen protein therapeutics. These disease models more accurately simulate in vivo pharmacology compared to traditional cell lines thereby increasing the likelihood of translational...
Apostle, Inc.   
Pleasanton, USA
Apostle Inc is a biotechnology company in San Jose, CA, a provider of technologies and services for public health and life sciences. Apostle aims to develop technologies in the space of liquid biopsy - the sampling and analysis of non-solid biological tissue, primarily blood, often utilizing circulating free DNA (cfDNA) as a biomarker.
Applied Biomedical Science Institute   
San Diego, USA
The Applied Biomedical Science Institute (ABS Institute) is a non-profit organization performing cutting-edge biomedical research involving biological mechanisms of disease pathogenesis and treatment, with a focus on biologics/antibody drug discovery. It specializes in early-stage biologic drug development, moving research from the lab to potential patient therapies.
APstem Therapeutics   
Fremont, USA
APstem is developing a cell therapy technology that uses a novel proprietary class of stem cells, Adult High Plasticity Stem Cells (AHPSC), to treat serious diseases that have long impacted human health. The pipeline is currently centered on preclinical development of therapies for serious chronic and degenerative diseases.
Ascella Biosystems   
San Francisco, USA
Ascella Biosystems is an early stage diagnostics company focused on the development and commercialization of a rapid handheld viral molecular RNA testing system. The company's RAIL™ technology offers sensitivity and specificity comparable to PCR. The features of company's products include, molecular detection, quick results, affordable, variant identification, handheld and parallel detection.
Atgenomix Inc   
Taipei City, Taiwan
Atgenomix is a data and machine learning company focused on biomedical data management and analysis for precision medicine applications. The company develops cloud-based platforms and software solutions that support large-scale processing, integration, and analysis of genomic and multi-omics data. Its technologies are used by next-generation sequencing (NGS) testing providers, clinical researchers, and bioinformatics developers to enable clinical diagnostics, research workflows, and deployment...
Atropos Therapeutics, Inc.   
San Carlos, USA
Atropos Therapeutics Inc. is a bio-pharmaceutical company focused on discovering and developing drugs against aging disorders and cancer using its proprietary senescence technology. The company's pipeline is preclinical stage and is NIH-funded.
Augmenta Bioworks, Inc.   
Menlo Park, USA
Augmenta Bioworks discover therapeutics by focusing on natural human immunity which harnesses the most powerful force in the fight against disease. The company utilizes advanced automation, microfluidics, high throughput DNA sequencing to identify the immune receptors and their specific antigen.
Aukera, Inc.   
Pasadena, USA
Aukera, Inc. develops, researches, and produces protein-based nanocapsules. The company uses its nCap™ technology to develop nanocapsule products for the delivery of therapeutic molecules. The firm's work focuses on applications of protein-based nanocapsules in drug delivery.
Avanti Biosciences Inc.   
San Diego, USA
Avanti Biosciences is a biopharmaceutical company, advancing an oral precision kinase inhibitor for idiopathic pulmonary fibrosis (IPF). The company's lead asset, ABI-171, is IND-ready with FDA Orphan Drug Designation, supported by a comprehensive preclinical package including human fibroblast mechanistic validation, functional in vivo endpoints, and head-to-head comparison with current standard of care.
Axbio Inc.   
Santa Clara, USA
AXBIO specializes in Bio-CMOS chips. Leveraging this technology, AXBIO have developed fourth-generation nanopore sequencers, multiplex nucleic acid analysis systems. AXBIO's nanopore sequencers utilize advanced electrochemical sensing, biochemical, and chemical synthesis technologies to overcome current sequencing limitations, offering cost-effective, long reads, high accuracy, high throughput, and real-time sequencing, which meet diverse research and clinical application needs across various...
Axiom Biosciences   
Carlsbad, USA
Cytonus Therapeutics Inc. was a U.S.-based biotechnology company focused on developing regenerative medicine and cell-based therapies for neurological disorders and other diseases with high unmet medical needs. The company specialized in allogeneic stem cell therapies, particularly Wharton's Jelly-derived mesenchymal stem cell (WJ-MSC) products, to treat conditions such as neonatal intraventricular hemorrhage (IVH), hypoxic-ischemic encephalopathy (HIE), and ischemic stroke. The company rebranded...
Baymedica Inc.   
Incline Village, USA
BayMedica is a scalable biosynthetic platform delivering natural cannabinoids including CBC, CBD, and CBG as well as novel cannabinoid analogs. The company is creating an efficient, patent-pending, biological factory by taking the blueprints for cannabinoid biosynthesis from the inefficient cannabis plant and engineering them into ultra-efficient brewer’s yeast.
BCD Bioscience, Inc.   
Davis, USA
BCD Bioscience, Inc. is a developer of naturally-derived oligosaccharides designed for food, agriculture, and biopharmaceutical applications. The company uses proprietary technology to create novel oligosaccharides from natural products, with a focus on producing ingredients that beneficially modulate the microbiome and immune function, enabling clients to access novel prebiotics, synbiotics, and immunomodulatory therapies for human and animal health.
Binacea Pharma Inc.   
Hayward, USA
Binacea Pharma, Inc. is a privately held biopharmaceutical company that researches and develops antibody-based therapeutics for cancer and other serious diseases. The company's technology interests include bispecific antibodies and nanobodies designed to improve therapeutic effectiveness, affordability, and patient convenience. The company has also described proprietary Brainbody technology, which aims to facilitate the delivery of therapeutic agents across the blood–brain barrier for neurological...
BioAmp Diagnostics   
San Carlos, USA
BioAmp Diagnostics is a biotechnology company developing rapid point-of-care diagnostic tests that use molecular and biosensor technologies to identify infections and support timely, evidence-based treatment decisions.
Bioeclipse Therapeutics   
Mountain View, USA
BioEclipse Therapeutics is a clinical-stage biotechnology company focused on the development of immuno-oncology therapies for cancer.The company's product CRX100 is an intravenous, first-in-class cancer immunotherapy. It combines patient immune cells (cytokine-induced killer cells) with an oncolytic virus to target, destroy, and trigger an immune response against refractory and recurring solid tumors. The company's other product, CRX200, is an investigational allogeneic cell therapy designed...
BioLum Sciences, LLC   
Dallas, USA
BioLum Sciences, LLC is a biotechnology company focused on advancing drug discovery, development, and early disease detection through sensitive biomarker analysis. The company provides bioanalytical chemistry and custom assay development services, with a focus on chemiluminescent and fluorescent technologies. The company develops chemiluminescence-based assays and platforms intended to support high-throughput biomarker screening and the future development of point-of-care in vitro diagnostic...
Biome Makers Inc.   
Davis, USA
Biome Makersis a developer of a microbiome technology designed to provide a functional understanding of soil to improve agricultural production and quality. The company's technology uses DNA sequencing and intelligent computing to provide detailed crop-specific insights and recommendations in a simplified manner, enabling growers and manufacturers to analyze the soil ecosystem and access data-driven insights. Biome Makers integrates soil microbiology into agricultural decision-making to optimize...
BioSuperior Technology, Inc.   
Los Altos, USA
BioSuperior Technology, Inc. is a preclinical-stage biotherapeutics company focused on developing innovative therapies for lung and respiratory diseases. The company’s platform is a bioengineered synthetic pulmonary surfactant (BioSurf™) designed to restore normal lung function and serve as a delivery system for potent therapeutics delivered into the lungs. The company’s lead program targets acute respiratory distress syndrome (ARDS) and bronchopulmonary dysplasia.
Bolt Biotherapeutics, Inc.   
Redwood City, USA
Bolt Biotherapeutics is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies. BBOT has the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors.
BridGene Biosciences, Inc.   
San Jose, USA
BridGene is a biotechnology company focused on discovering and developing innovative small molecules that drug traditionally undruggable targets, providing new paths to treat diseases. By using company's proprietary chemoproteomic platform, IMTAC™, BridGene is able to screen small molecules against all proteins in live cells to discover drug candidates for high value and previously undruggable targets. BridGene is advancing a diversified pipeline of first-in-class drugs for targets in multiple...
Brightseed   
South San Francisco, USA
Brightseed is a biotechnology and health science technology company that develops AI-powered platforms for the discovery and characterization of bioactive compounds from natural sources. Its technology combines biological data, metabolomics, and artificial intelligence to support the identification and development of ingredients and compounds for applications in human health and nutrition.
CAGE Bio Inc.   
San Carlos, USA
CAGE Bio Inc. is a privately-held clinical-stage company, which is a developer of a eutectic ionic liquid platform designed to minimize the pervasive use of systemic drugs for the treatment of dermal diseases and symptoms. The company's product is based on ionic liquid technology which offers broad-spectrum antimicrobial and anti-inflammatory properties along with enhancement of solubility and permeability, enabling physicians to treat dermal diseases successfully and effectively using effective...
Cairn Biosciences   
San Francisco, USA
Cairn Biosciences is a biopharmaceutical company focused on the discovery of novel therapeutics through the study of cellular dynamics. The company utilizes its proprietary COMPASS discovery platform to simulate living biology, enabling the mapping of multiscale cellular behaviors and adaptations over time.
Calyx Inc.   
Berkeley, USA
Calyx Inc. develops agricultural technology for poultry farming operations. The company integrates computer vision, bio-engineered sensors, and data analytics to monitor live birds and farm environments. The company's product line includes the AI Eye camera for automated flock weight tracking, the Y-Series multi-sensor system for measuring ammonia, carbon dioxide, temperature, and humidity, and the Calyx Connect platform for data visualization and system integration via API.
Capulus Therapeutics, LLC   
San Francisco, USA
Capulus Therapeutics is an SF-based biotech focused on targeting the root cause of disease with a novel predictive, AI-guided approach to drug discovery and development. The company's work in ‘Engineering drug design’ involves the development of new drug candidates using approaches and cutting-edge technologies. This includes using computational methods to design molecules that are more likely to be effective in targeting specific disease pathways and using advanced screening technologies...
Celldom, Inc.   
San Carlos, USA
Celldom is a developer of single-cell analysis technology designed for advanced research, drug discovery, and drug development by illuminating diversity in cell populations. The company's technology integrates both phenotypic and genomic data at a massive scale to identify and characterize rare cells that play critical roles in biological pathways and disease, enabling clients to get computerizing single-cell biology to automate the unmasking of cellular heterogeneity for every biologist.
CellFE Inc.   
Hayward, USA
CellFE, a cutting-edge microfluidics company, is transforming the development and manufacturing of lifesaving cell therapies to make them more accessible to patients. The company aims to unlock the full potential of this transformative modality by tackling its key market challenges, notably high manufacturing costs and extended vein-to-vein timelines. With a focus on T-Cell, HSC, and iPSC-based therapies, CellFE’s microfluidics-based gene-delivery technology, in conjunction with proprietary...
CellSight Technologies, Inc.   
San Francisco, USA
CellSight Technologies is a privately held clinical stage molecular imaging company. The company's mission is to commercialize PET (Positron Emission Tomography) imaging products to visualize immune response to aid in development of immunotherapies and clinical management of patients.
Checkerspot, Inc.   
Alameda, USA
Checkerspot is a materials innovation company that designs materials at a molecular level. The company is driven by a mission to use the power of biotechnology to expand the palette of molecular building blocks for high-performance and sustainable materials.
Chi Botanic Inc.   
Alameda, USA
Chi Botanic Inc. is a biotechnology company that develops plant cell culture technologies to produce botanical ingredients without conventional farming methods. The company isolates specific plant cell lines and cultivates them within controlled laboratory environments using nutrient-rich solutions rather than soil, pesticides, or extensive land and water resources. This bioreactor-based cultivation allows for the targeted production of specific plant-derived bioactive compounds under standardized...
Chimera Bioengineering   
South San Francisco, USA
Chimera Bioengineering is a biotherapeutics company focused on building control systems for chimeric antigen receptor (CAR) T cell therapeutics. The company develops gene therapeutics designed to re-program the immune system and treat cancer. The company's therapeutics are immune cells hot-wired to circumvent immune evasion and redirect them to find and kill tumor cells that are decorated with a defined target antigen, enabling unresponsive patients to recover against solid tumor cancer and...
CHO Plus, Inc.   
South San Francisco, USA
CHO Plus has developed patented technology for creating highly productive cell lines to be used for the production of therapeutic proteins and viruses. Their core business revolves around the development and licensing of advanced cell-line engineering technologies. Specifically, they produce high-productivity, GMP-compliant mammalian cell lines optimized for manufacturing therapeutic proteins and viruses.
Chronus Health   
Fremont, USA
Chronus Health develops a diagnostic device for CBC and CMP tests. The company's portable device allows for real-time diagnosis at the point of care, providing lab results in minutes, dramatically improving time to care and patient outcomes. Chronus Health's system leverages microfluidics and semiconductor technology combined with analytics using data science tools to deliver real-time blood test results, enabling healthcare providers to have access to immediately actionable data and improve...
CitraGen Pharmaceuticals, Inc.   
Fremont, USA
CitraGen Pharmaceuticals, Inc. develops, manufactures and markets drug products. The company's pipeline includes, over-the-counter (OTC) products (including cutting-edge first to market branded OTC products), prescription generics (ANDA), and new drug products (NDA).
CLEO Life Sciences   
South San Francisco, USA
Cleo Life Sciences is a general Chemistry, Manufacturing, and Controls (CMC) consulting firm with an R&D lab and product prototyping facilities. Cleo provides a variety of services to clients to facilitate pharmaceutical product innovation. These include: strategic and tactical management of CMC programs, oversight of contract manufacturing organization (CMO) projects drug substance and drug product, dosage form development, technology transfer, CMC regulatory writing and representation to...
Coastar Therapeutics, Inc.   
San Diego, USA
Coastar Therapeutics, Inc. is a company developing biological delivery technologies for cancer immunotherapy and gene therapy. The company has developed a proprietary erythrocyte-derived membrane (EDM) technology that uses red blood cell-derived membranes to coat genetic medicine payloads, including DNA and RNA, with the aim of reducing immune system clearance and improving targeted delivery to disease sites. Its development programs include in vivo CAR-T approaches for systemic lupus and blood...
Compound Foods, Inc.   
San Francisco, USA
Compound Foods, Inc. is a California-based food science company focused on investigating the enhancement and creation of new foods with the combination of food science, fermentation and synthetic biology.
Conception   
Berkeley, USA
Conception is generating viable eggs from stem cells. The company is working to create viable human eggs from iPSCs which is induced to Primordial Germ Cell Like Cells (PGCLCs). The company is working with the complex human and mouse tissue culture techniques, including primary culture, 3D organoid culture, imaging, and analytics. The company is generating eggs for fertility purposes, for women/couples with fertility problems. The technology will help to eliminate the maternal age fertility...
Convalesce Inc.   
San Francisco, USA
Convalesce is a therapeutic company enabling stem cell-based therapy for neurodegenerative conditions like Parkinson's, harnessing state-of-art biomaterials.
Convergent Genomics   
South San Francisco, USA
Convergent Genomics is a precision medicine company that combines advances in genomics and machine learning to detect cancer early and non-invasively. The company transforms cancer care through data analytics.
Correlia Biosystems   
Berkeley, USA
Correlia Biosystems is a biotechnology company that develops protein analysis technologies and laboratory instruments for life science research. Its proprietary platform enables rapid, high-sensitivity protein detection and characterization from small sample volumes, helping researchers accelerate biomarker discovery, drug development, and translational research.
Creyon Bio, Inc.   
Carlsbad, USA
Creyon Bio is a clinical-stage biotechnology company focused on developing precision nucleic-acid medicines using artificial intelligence and molecular engineering. The company designs oligonucleotide-based therapeutics (OBMs) including antisense oligonucleotides (ASOs), small interfering RNA (siRNA), and aptamers to target the genetic causes of disease.
Crossignal Therapeutics, Inc.   
La Jolla, USA
Crossignal Therapeutics, Inc. is a biotechnology company that focuses on developing small molecule anti-cancer immunotherapies. The company concentrates its research on the tumor microenvironment (TME), specifically targeting immune cell-expressed G-protein coupled receptors (GPCRs), which they refer to as tumor metabolic factors-targeted GPCRs (TMERs). The company's product CT3001 is an oral, first-in-class small molecule inhibitor of GPR35 being developed to overcome tumor immunosuppression.
Cybele Microbiome Inc.   
San Diego, USA
Cybele Microbiome is a developer of customized skincare products created to target an individual's own microbiome for improving skin health. The company's products are developed using genetic sequencing methods with a sustainable source of nutrients that strengthen an individual's skin's natural barrier, thereby enabling them to maintain the integrity of their skin through conscientious skincare.
Cyclarity Therapeutics, Inc.   
Novato, USA
Cyclarity Therapeutics, Inc. is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. The company's UDP-003 is an investigational, first-in-class engineered cyclodextrin developed...
cystetic Medicines, Inc.   
San Carlos, USA
Cystetic Medicines is a clinical-stage biotechnology company developing small-molecular prosthetics for cystic fibrosis (CF). The firm's product candidate, CM001, is an investigational-inhaled therapy formulated as a dry powder that forms ion channels in airway epithelial cell membranes to support anion transport and pulmonary function. CM001 is being developed for people with cystic fibrosis, including those who cannot benefit from existing CFTR modulator therapies.
D&P Bioinnovations, Inc.   
San Diego, USA
D&P Bioinnovations, Inc. is a regenerative medicine company focused on repairing damaged organs with unique biomaterials and immunomodulatory stem cell factors. The company's first commercial therapeutic application for the implant is to regenerate a damaged esophagus to treat esophageal cancer and other sever ailments of the esophagus (i.e., Advanced Barrett's, GERD, pediatric atresia, physical trauma, etc.)
Daré Bioscience, Inc.   
San Diego, USA
Daré Bioscience, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of therapeutics, medical devices, and consumer health products for women’s health indications. The company’s pipeline spans reproductive health, contraception, vaginal health, sexual health, fertility, menopause, and infectious diseases, and includes both pharmaceutical and device-based product candidates under clinical and commercial development.
DelNova, Inc.   
San Diego, USA
DelNova, Inc. is a privately held biopharmaceutical company developing innovative therapeutics using clinically validated molecules linked to advances in drug delivery to solve unmet medical needs. The company's lead clinical candidate, ReViVox®, is designed to rescue complications caused by off-target muscle paralysis following aesthetic and medical neurotoxin therapies, specifically botulinum toxins type A (e.g., Botox®). DelNova is resolving complications arising from botulinum toxin therapies...
Delpor, Inc.   
Brisbane, USA
Delpor, Inc. is a clinical-stage biotechnology company developing long-acting implantable therapies for the treatment of chronic diseases. The company focuses on drug-device combination products designed to provide sustained drug release for up to one year from a small subcutaneous implant. Delpor’s proprietary technology platforms include PROZOR™, a formulation system enabling controlled release of poorly soluble drugs, and NANOPOR™, a nanoporous membrane technology designed to achieve...
Demetrix, Inc.   
Berkeley, USA
Demetrix, Inc. manufactures natural medicines using synthesis biology. The company uses genetics and computing enabled deciphering technology to produce drugs. The company enables the refactoring biotechnology microbial hosts for gene synthesis.
Demonpore Inc.   
Richmond, USA
Demonpore Inc. is a biotechnology company which specializes in building mechanical nanopores to create a molecular sensing platform. The company builds mechanical, nanopore-based molecular sensors. Its core product, originally named the demonpore 64 and updated as the MR1 Molecular Streaming Device, is engineered as a molecular gaming console.
DermBiont, Inc.   
Boston, USA
DermBiont is a dermatology company leveraging skin microbiome therapeutics (live biotherapeutics) to treat the root cause of skin diseases. In addition to the company’s lead product in development to treat onychomycosis and atopic dermatitis, DBI-001, the company is advancing four other clinical assets across a wide range of skin diseases caused by a dysbiosis of the microbiome.
Drugs & Diagnostics for Tropical Diseases   
San Diego, USA
Drugs & Diagnostics for Tropical Diseases (DDTD) is a unique non-profit venture based in San Diego, CA, with a mission to discover new treatments and develop diagnostics for neglected tropical diseases. These diseases have been typically neglected from research and development efforts due to the perceived lack of profitability and are commonly referred to as Neglected Tropical Diseases or NTDs. As part of their mission, DDTD is developing rapid diagnostics to specifically detect infections associated...
Dynomics   
San Francisco, USA
Dynomics, Inc. develops human cardiac organoids for drug discovery, toxicology screening, and cardiovascular disease research. The company uses organoid models designed to represent features of adult human heart tissue to support the study of cardiac function and the evaluation of therapeutic candidates and potential toxic effects.
Eclipse BioInnovations Inc.   
San Diego, USA
Eclipse BioInnovations Inc. is a biotechnology start-up company focused on specialized genomics technologies. The company’s eCLIP is offered as a service and kit for biopharma companies and academic researchers and can be customized for different RNAs, such as siRNA or miRNA. Eclipse BioInnovations technology focuses on increasing crosslinking and immunoprecipitation and assists in identifying ribonucleic acid binding protein targets, enabling scientists and academic customers to accelerate...
Elegen Corp   
Menlo Park, USA
Elegen Corp is a developer of microfluidics technology designed to disrupt synthetic biology. The company leverages technology for the engineering of entire genomes and the rapid development of DNA synthesizers aimed at accelerating biomedical advances, enabling the healthcare industry to facilitate DNA sequence testing. Elegen applies technology and methods to produce DNA products that are fundamentally differentiated and disruptive. ENFINIA DNA is high-accuracy, linear, double-stranded DNA.
Element BIO Inc.   
Denver, USA
Element BIO Inc. is a Denver based sales and distribution company which provides biobased industrial lubricants, cleaners and solvents. The company provides solutions to manufacturing, energy industries, and governments that reduce toxicity throughout their operations and facilities.
Emanate Biomedical Inc.   
New York, USA
Emanate Biomedical is a category-defining medical device platform company focused on oral health. The company is headquartered in New York and has a dedicated R&D center in the San Francisco Bay Area.
EmPowerYu   
Santa Clara, USA
EmPowerYu has created an intelligent remote monitoring system that improves healthcare, reduces costs, and improves communication between monitored persons, families and professional caregivers. The company operates at the intersection of big data, the Internet of things, and healthcare. EmPowerYu is a proprietary software analytics platform that quantifies data from daily behavior like eating, sleeping, activity, and device usage, and integrates it with patient-generated medical data to produce...
Encellin   
Pleasanton, USA
Encellin is an innovative biotechnology company developing an Encapsulated Cell Replacement Therapy (ENCRT) platform, aimed primarily at treating type 1 diabetes and other endocrine diseases. Their flagship product is a tiny implantable pouch made of a nanoporous membrane that houses therapeutic insulin-producing cells while protecting them from the body's immune system.
Encodia, Inc   
San Diego, USA
Encodia is a privately held biotechnology company bringing the power of sequencing to proteomics. The company's patented ProteoCode technology enables protein analysis via an accessible and easy-to-use benchtop instrument. Tools employing Encodia's ProteoCode technology will drive new biological understanding with impact in data-driven drug discovery and development, new high-complexity diagnostics, and beyond.
EnduRx Pharmaceuticals Inc.   
Tucson, USA
EnduRx, a virtual, pre-clinical company, is developing a peptide-directed nanoparticle drug delivery platform and therapeutics for hard-to-treat solid tumors and selected other indications. EnduRx therapeutic candidates are polymeric nanoparticles designed to achieve tumor-specific delivery of active pharmaceutical ingredients (API’s) that internalize into cells throughout the tumor parenchyma while avoiding healthy tissue.
Entelexo Biotherapeutics   
Irvine, USA
Entelexo Biotherapeutics is a privately held biotechnology company developing engineered exosome-based therapeutics for the treatment of complex autoimmune and immune-mediated diseases. Entelexo has created a proprietary exosome engineering platform that enables therapeutic exosomes to deliver targeted signals to multiple diseased cell types simultaneously, addressing the multifactorial nature of autoimmune disorders. The company pipeline focuses on diseases such as rheumatoid arthritis, Crohn’s...
Envivo Bio Inc.   
San Francisco, USA
Envivo Bio is a biotech company advancing the gut microbiome and metabolome field. The company has developed CapScan, an investigational ingestible device designed to sample and analyze the gut regionally.
Epalex Corporation   
Mountain View, USA
Epalex is a clinical-stage pharmaceutical company developing therapies for migraine and epilepsy. The company's drug candidates provide effective relief. The company is developing EP102 for the acute treatment of migraine headache pain and related symptoms and EP103 for the control of seizure disorders such as epilepsy.
Epicrispr Biotechnologies   
South San Francisco, USA
Epic Bio is an epigenetic editing company that modifies gene expression without cutting DNA sequences. The company's product EPI-321 is an investigational epigenetic therapy that aims to address the underlying molecular mechanisms of FSHD with a one-time dose. The company's another product EPI-331 is an experimental, in vivo epigenetic therapy for Duchenne muscular dystrophy (DMD).
Epigen Biosciences, Inc.   
San Diego, USA
Epigen Biosciences is a pharmaceutical company that is discovering proprietary drugs to address unmet medical needs. The company employs advanced hit-to-lead and lead optimization techniques. These encompass computational design, scaffold-hopping, focused library synthesis, and screening. Epigen harness cutting-edge in silico drug discovery tools, intricately coupled with meticulous property assessment for Absorption, Distribution, Metabolism, and Excretion (ADME). These methodologies and processes...
Epigenome Technologies   
San Diego, USA
Epigenome Technologies, Inc. is focused on developing advanced tools and analytical platforms to study epigenetic regulation at single-cell resolution. The company applies multi-omics technologies to measure epigenetic marks such as DNA methylation, chromatin accessibility, and gene-expression changes across individual cells, enabling a deeper understanding of disease biology. Epigenome Technologies platforms are designed to support academic, pharmaceutical, and clinical researchers working...
Esvyda! Inc   
Campbell, USA
Esvyda is a virtual care solution HIPAA compliant for healthcare providers that allows secure communication, video, remote patient monitoring of vital signs such as blood pressure, weight, glucose, oxygen and temperature and physical activity using wearables. providing relevant data to clinicians, care teams and caregivers. The firm is now offering an exam room app, which helps to provide error-free information of vital signs directly uploaded to medical records of patients previous face-to-face...
Eternal Technology Corporation   
Colonial Heights, USA
Eternal Technology CORP's line of business includes the wholesale distribution of miscellaneous industrial supplies. The company focuses on the production of PCB boards. Some of the products are NIT200 Series, LDF515F, UD900 Series etc.
ExcepGen   
San Francisco, USA
ExcepGen, Inc. is a privately held biotechnology company focused on developing technologies for RNA medicines, vaccines, gene therapies, and other biotherapeutics. Its key technology is the RNAx platform, an mRNA-encoded protein designed to modify the cellular response to RNA and lipid nanoparticles (LNPs) by dampening excessive innate immune activation. The company is currently focused on self-amplifying mRNA vaccines, trans-amplifying mRNA vaccines, and conventional mRNA vaccines.
Exinda Therapeutics LLC   
Sacramento, USA
Exinda Therapeutics is dedicated to developing pharmaceuticals in oncology and immunomodulation.
EYSZ   
Berkeley, USA
Eysz, Inc. is developing a software-based digital therapeutic built on patented eye-tracking algorithms that have the potential to identify seizures, track side effects and respond to medications in real time.
Fabric8Labs Inc.   
San Diego, USA
Fabric8Labs is revolutionizing additive manufacturing by providing the 3D printer for metal components. The company developed a unique process that is an intuitive combination of two mature technologies: Stereo-Lithography and Electro-Deposition. Using a sophisticated control system, the printer deposits metals, producing parts quickly and effectively at room temperature and pressure.
FaradPower Inc.   
Sunnyvale, USA
Farad Power Inc. is a pioneer in the field of innovative materials for energy storage devices. The company has developed patented technology to fabricate high-performance carbons suitable for next-generation applications like energy-storage, and gas-phase and liquid-phase applications. The company also developed lab-scale processes that are now being scaled up to pilot-plant volumes, to provide sampling capabilities for customers in different application segments.
Fauna Bio Incorporated   
Emeryville, USA
Fauna Bio Incorporated is a mammalian genomicist and a research-trained veterinarian inspired by the untapped potential of non-model organism biology. The company develops novel translational therapeutics for disease prevention and reduces the impact of age-related diseases in humans. Fauna Bio's platform uses animal genomics, transcriptomics, metabolomics, and proteomics data across a range of species to identify novel drug targets and develop therapeutics for multiple human disease indications,...
Filtricine, Inc   
Santa Clara, USA
Filtricine, Inc is a biotechnology company which develops a drug-free cancer therapy based on nutrient deprivation.
Finless Foods Inc.   
Oakland, USA
Finless Foods is an early-stage biotechnology company, the mission of which is to develop and mass manufacture marine animal food products for human consumption. The cellular biology seafood company uses cellular-agriculture technologies to grow marine-animal cells, creating fish and seafood products.
Flightpath Biosciences, Inc.   
Detroit, USA
Flightpath Biosciences, Inc. is a private, clinical-stage biotechnology company focused on developing microbiome-sparing, narrow-spectrum antibiotics to treat infection-driven complex diseases. The company utilizes a "Targeted Bacterial Deletion™" platform to remove harmful pathogens while preserving beneficial bacteria.
Fornia BioSolutions, Inc.   
Hayward, USA
Fornia BioSolutions Inc. is a biotechnology research service company, specializing in the development of microbial products for the agricultural, aquacultural, food processing, feed, household/personal care, and environmental markets. The company provides a full range of industry-leading technologies for product development, from computational design/analysis, high-throughput strain/protein mutant construction, and high-throughput screening, to shake flask and fermentation validation.
Foundery Biosciences   
San Francisco, USA
Foundery Biosciences is a San Francisco-based Immunotherapy Venture Studio; a novel scientist-driven enterprise accelerating early-stage R&D. The company aims to develop transformative immunotherapies and mint next-generation immunotherapy companies to treat high unmet need diseases caused by dysfunctional immunological responses.
Fountain Therapeutics   
South San Francisco, USA
Fountain Therapeutics is a biotechnology company focused on the development of pharmacological interventions for chronic degenerative and age-related diseases. The company utilizes a proprietary discovery platform that integrates computer vision, artificial intelligence, and machine learning to analyze the biological and phenotypic characteristics of cells. The company's FTX008762 is a novel small-molecule modulator to preserve muscle mass and prevent the progression of lean tissue and muscle...
Frontier Bio Corporation   
Eric Bennett
Hayward, USA
Frontier Bio Corporation is a biotechnology company focused on developing lab-grown human tissues to replace animal testing and eventually address the global organ transplant shortage. The company has developed 3D bioprinting technology with applications in medicine and drug development. Also, Frontier Bio developed a bioprinter that combines conventional bioprinting techniques with electro-hydrodynamic printing (EHDP). Their patent-pending technology is the only method that can print at the...
Frontier Medicines Corporation   
South San Francisco, USA
Frontier Medicines is a company developing precision medicines for genetically defined patient populations, with a focus on oncology and immunology. The company uses its proprietary Frontier™ Platform, which combines chemoproteomics, covalent chemistry and machine learning to identify and develop therapeutics targeting disease-associated proteins that are difficult to drug. The company's product FMC-376 is an orally bioavailable, covalent small-molecule drug that acts as a first-in-class dual...
Fustibal LLC   
San Francisco, USA
Fustibal is a biotechnology company focused on fostering affordable healthcare through simpler science. The company develops targeted nanomedicines by repurposing and improving existing chemical and biological pharmaceuticals for efficacy, safety, and unmet medical needs. The company's kinetics-based, proteomic-driven platforms and therapeutics are cancer-focused but have broad medical applications.
GattaCo Inc.   
Murrieta, USA
GattaCo Inc. is a developer of diagnostics equipment intended to simplify pre-analytical sample collection and processing methods. The company's equipment is fully automatic, disposable, high-yield rapid plasma separation and metering tool meant for centrifuge replacement, enabling healthcare professionals to conduct quality blood purification at an effective cost.
Geltor, Inc.   
Emeryville, USA
Geltor is a biodesign company, producing protein ingredients, replacing animal-derived and harsh chemical processes with sustainable, ethical, and effective alternatives. Through microbial fermentation, Geltor designs, produces, and distributes bioactive proteins for various industries, including beauty, healthcare, and consumer goods.
GeneLancet Biosciences, Inc.   
Doylestown, USA
GeneLancet Biosciences, a gene editing company, commercializes proprietary ligated single molecule guide RNAs (LgRNA) and arrayed lgRNA libraries. The company develops non-immunogenic LgRNA-guided STAR Editing platform for precise, multiplexing, and multiple-dosing genome editing. The company's lgRNA-guided gene editing platform with therapeutic areas of interest include chronic HBV, rare monogenetic diseases, Alzheimer’s and other diseases with significant unmet needs.
GigaGen, Inc.   
South San Francisco, USA
GigaGen Inc., is a biotechnology company advancing transformative antibody drugs for immunodeficiencies, infectious diseases and checkpoint-resistant cancers, and is a subsidiary of Grifols. GIGA-2339 is the clinical lead of GigaGen’s recombinant polyclonal antibody pipeline.
Girihlet Inc.   
Oakland, USA
Girihlet Inc. is a sequencing company that provides non-canonical genomics solutions. The company engages in profiling the T cell receptor repertoire to develop an understanding of the immune system for diagnostic and therapeutic applications.
Gladstone Institutes   
San Francisco, USA
Gladstone is an independent and nonprofit biomedical-research organization dedicated to accelerating the pace of scientific discovery and innovation to prevent, treat and cure cardiovascular, viral and neurological diseases. Gladstone is affiliated with the University of California, San Francisco.
GluBio Therapeutics, Inc.   
San Diego, USA
GluBio Therapeutics is a company dedicated to the discovery and development of small molecule medicines by harnessing the power of targeted protein degradation (TPD). Using a proprietary TPD discovery platform and robust screening capabilities, the company is advancing a diverse pipeline of selective small-molecule degraders across multiple therapeutic areas.
GlyTR Therapeutics, Inc.   
Irvine, USA
GlyTR Therapeutics is a biotech company developing an entirely new class of immunotherapeutic anti-cancer molecules and cells.
Gordian Biotechnology   
South San Francisco, USA
Gordian Biotechnology is a therapeutics company pioneering a novel screening platform to radically increase the efficiency of development for complex diseases of aging.
Gossamer Bio, Inc.   
San Diego, USA
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company developing therapeutics for pulmonary vascular diseases. The company is developing seralutinib for pulmonary hypertension associated with interstitial lung disease (PH-ILD). Gossamer Bio conducts research and clinical development activities for its product candidates.
GraphWear Technologies   
San Francisco, USA
GraphWear Technologies, Inc. is a San Francisco-based medical technology company that develops needle-free, non-invasive technologies for continuous monitoring of chronic diseases. The company's lead investigational product is a nanotechnology-based continuous glucose monitoring wearable designed to measure glucose without needles or blood samples and is being developed for diabetes management.
Gryphon Bio, Inc.   
South San Francisco, USA
Gryphon Bio is a preclinical-stage therapeutic bioconjugate company created to harness the discovery of novel therapeutic targets and temporal biomarkers in unexpected waves of brain molecules in the blood. The company's mission is to develop and market the therapeutic bioconjugate to accelerate brain repair and improve cognition.
Haystack Science   
New York, USA
Haystack Science is a boutique consulting firm specialized in identifying, vetting and maximizing the translational potential of academic projects and preclinical companies.
Helio Genomics   
Irvine, USA
Helio Genomics is a commercial stage, AI-driven healthcare company specializing in diagnostics technology to pioneer cancer early detection and minimal residual disease monitoring. Helio Genomics' advanced blood-based multi-analyte platform uses machine learning and deep learning to detect cancer biomarkers with unprecedented accuracy, empowering clinicians and patients to act swiftly in the fight against liver cancer. This technology has been clinically validated in studies with thousands of...
Hepatx Corporation   
Palo Alto, USA
HepaTx Corporation is developing regenerative stem cell therapies to treat end-stage liver disease, offering a non-surgical alternative to organ transplants. The company's pipeline utilizes proprietary Stanford technology to convert adipose-derived stem cells into functional, hepatocyte-like cells designed for simple, off-the-shelf infusion.
Herophilus   
San Francisco, USA
Herophilus is a company discovering drugs for brain diseases using human cerebral organoids. The company leverages AI-driven phenotypic screening, cerebral organoid science, systems neuroscience, robotic automation, and data analytics to identify novel therapeutic targets and drug treatments for epilepsy, autism, schizophrenia, etc.
Hummingbird Bioscience   
South San Francisco, USA
Hummingbird Bioscience is a therapeutics development company with a proprietary rational antibody discovery platform and applying integrative genomics and proteomics. Hummingbird develops precision therapeutic antibodies to clinical proof-of-concept for patients with the highest unmet need.
IGE Technology Inc   
San Diego, USA
IGE Technology, Inc. is a biotechnology company specialized in development and manufacture of immunoassays. The company's products are a series of automated chemiluminescence immunoassay. All products are plate-based, medium-throughput assays carried by automation. The most advanced product is an assay kit for qualitative detection of certain parasite antigens in veterinary specimens.
IHP Therapeutics   
San Carlos, USA
IHP Therapeutics is the therapeutic company which is applying Glycobiology to develop novel medicines. IHP compounds are novel small molecule glycan therapeutics that inhibit selectin and complement activity. IHP’s lead compound, IHP-102, is a dual P-selectin and complement inhibitor, which targets diseases in hematology and oncology. IHP-102 has potential as a prodromal rescue therapeutic for sickle cell disease patients in vaso-occlusive crisis.
Immunomab, Inc.   
Richmond, USA
Immunomab, Inc. is a biotechnology company focused on developing antibody-based therapeutics for cancer. Based in San Diego, California, it focuses on developing antibody-based therapeutics targeting various cancers through innovative research and treatment advancements. The company has been described in industry directories as working on antibody therapeutics aimed at addressing oncologic targets.
INanoBio, Inc.   
Scottsdale, USA
INanoBio is a privately-held nano-biotechnology company that specializes in early cancer detection and high-speed genome sequencing. The company integrates nanotechnology, systems biology, and machine learning to develop high-accuracy diagnostic tools. INanoBio is developing an advanced 3D nanopore – transistor device for sequencing the whole human genome with high accuracy, at one-tenth the current cost and time.
Indaptus Therapeutics   
New York, USA
Indaptus Therapeutics, Inc. is a biotechnology company focused on developing therapeutic solutions, including early-stage research into potential neurotechnology and neural-network-based devices aimed at treating certain sleep-related conditions. The company’s activities center on research and development and general corporate operations, with an eye toward potential future regulatory submissions in the healthcare sector.
Indee Labs   
Berkeley, USA
Indee Labs is a biotechnology startup develops and markets hydropore for more effective engineered cell therapies. The company's non-viral delivery platform, Hydropore, is a robust solution that overcomes the limitations and costs of electroporation, viral transduction, and other non-viral transfection methods.
Infixion Bioscience, Inc.   
San Diego, USA
iNFixion Bioscience, Inc. is a preclinical drug discovery company developing disease-modifying therapies for Neurofibromatosis Type 1 (NF1). The company is focused on restoring functional neurofibromin protein to address the root cause of NF1, with the goal of treating and preventing the progression of the disease's diverse clinical manifestations regardless of the patient's specific genetic mutation.
Inflammatix, Inc.   
Sunnyvale, USA
Inflammatix is a molecular diagnostics company developing innovative host-response technologies that analyze the patient’s immune system to deliver rapid, actionable results. The company focuses on acute infections and sepsis, leveraging proprietary biomarkers and advanced machine learning to enable physicians to make timely and accurate treatment decisions, ultimately improving patient outcomes and reducing significant public health burdens.
Initial Therapeutics, Inc.   
South San Francisco, USA
Initial Therapeutics, Inc. is an early stage pharmaceutical discovery company which was created to make medicines that block notoriously difficult-to-drug protein targets with a new mode of action: selective termination of protein synthesis (STOPS).
iSono Health, Inc.   
San Francisco, USA
iSono Health, Inc. develops a wearable solution to monitor breast health. The company's ATUSA is a fully automated, hands-free scanning breast system designed for use by physicians, nurses, and medical assistants. The device consists of a 3D ultrasound scanner, a wearable component, and a Windows application for desktop and tablet computers for real-time image display, as well as review and measurement. The system also includes a web-based application for remote viewing with advanced 3D visualisation....
Jenthera Therapeutics Inc.   
Saint-Laurent, Canada
Jenthera Therapeutics is a biotechnology company leveraging a novel non-viral, non-lipid CRISPR platform for the development of groundbreaking therapeutics. The company's lead internal program in B-cell lymphoma unlocks a new frontier in CAR-T developments using the company's platform’s high frequencies of homology-directed repair to deliver in-vivo CAR insertions; while the program in non small cell lung cancer targets KRAS, a highly prized undruggable oncology target, and represents the...
JP BioMedicals, Inc.   
Davis, USA
Elliplex Inc. is a company focused on producing antigens used by diagnostic manufacturers to develop autoimmune diagnostic kits. The company provides antigen products intended to support reliable autoimmune disease testing and diagnostic development.
Juno Biomedical, Inc.   
San Jose, USA
Juno Biomedical is a developer of novel regenerative medical devices and therapies intended to repair brain damage caused by neurological disease and trauma. The company's novel regenerative medical devices and therapies aim to repair damaged brain tissue after stroke to reduce disability and return independence to stroke survivors, enabling patients to reduce neurological damage and optimize freedom for stroke survivors.
Kainomyx Inc.   
Mountain View, USA
Kainomyx is a biotechnology company developing novel therapeutics and diagnostics based on cytoskeletal biology. The company leverages its platform to identify and target cytoskeletal mechanisms in parasites, with a focus on addressing diseases in humans, animals, and agriculture. Its programs are primarily directed toward parasitic infections, including malaria, using a small-molecule drug discovery approach.
Karamedica   
Raleigh, USA
Karamedica’s goal is to expand medical and veterinary uses of biopolymer-based products, especially those containing chitosan, by developing novel decontamination processes like non-thermal plasmas. They also creates innovative medical devices and drug delivery systems based on these biopolymers.
Kenjockety Biotechnology, Inc   
South San Fransisco, USA
Kenjockety Biotechnology is developing a new family of bispecific antibodies (BsAbs) to address the significant unmet need for drug resistance in patients with cancer. The company's proprietary BASE™ platform is creating an extensive pipeline of new therapeutics by pairing the foundational antibodies that target efflux pumps (EPs) with antibodies to known tumor associated antigen (TAA) targets, to construct BsAbs that more effectively target tumor cells versus normal cells.
Khloris Biosciences, Inc.   
San Jose, USA
Khloris Biosciences, Inc. is an American biotechnology company pioneering a novel approach to cancer vaccination and cardiovascular medicine using patient-derived induced pluripotent stem cells (iPSCs). The company uses patient-specific or allogeneic iPSCs to trigger a multi-faceted anti-tumor immune response. These vaccines expose the patient's immune system to a broad range of cancer-related and oncofetal antigens, helping to actively target or prevent tumors.
Kinetiq   
Fort Worth, USA
Kinetiq is engaged in the development of next generation replacement enzymes that decrease the treatment burden for people with rare diseases. The company's internship program provides graduate students in the Los Angeles area with hands-on experience in early-stage life sciences business development. The internship program provides guidance through the practical aspects of commercializing innovation including product development, market analysis and regulatory requirements.
Knowledge Synthesis Inc.   
Berkeley, USA
Knowledge Synthesis accelerates and improves medical discovery by revealing the significance of large-scale experimental data across broad biological contexts. The company provides expert consulting, project management, and implementation for biomedical data integration efforts and data analysis.
Koniku Inc   
San Rafael, USA
Koniku Inc. is a neurotechnology company, develops co-processors made of biological neurons. The company offers devices for use in drug discovery and defense applications; and develops libraries for computational applications.
LamaMed Solutions, Inc.   
Hayward, USA
Lamamed solutions, inc is a medical device development firm. The company specializes in the design, development, and rapid manufacturing scale-up of unique catheter systems, mechanical devices, and both resorbable and non-resorbable implants.
Lassogen, Inc.   
San Diego, USA
Lassogen, Inc. is a privately held biotechnology company based in San Diego that is developing a new class of programmable peptide therapeutics called Lassotides™, derived from naturally occurring lasso peptides. The company focuses on creating treatments for challenging diseases, particularly cancer and autoimmune disorders. Lassogen's proprietary platform combines synthetic biology, protein engineering, machine learning, and high-throughput screening to discover and optimize lasso peptide-based...
Lectenz Bio, Inc.   
Athens, USA
Lectenz Bio is commercializing enabling technologies for applications in glycoscience and delivering tools that advance research and clinical applications. The company's Lectenz® reagents are engineered with high affinity and specificity for glycan structures of interest. The company is also translating the Lectenz® technology into an easy-to-use application platform called GlycoSense™ for glycan detection and analysis in applications such as disease biomarker detection and bioprocessing...
LifeLipids   
San Diego, USA
Life Lipids is a manufacturer of bioactive, structural, and otherwise interesting lipids for the purposes of research and development in the advancement of human medicine.
Ligandal Inc.   
San Francisco, USA
Ligandal is a biotechnology and precision medicine company focused on targeted delivery systems for advanced therapeutics such as mRNA, CRISPR, gene therapies, and nanoparticle-based medicines. The company describes itself as building a “Delivery OS for precision medicine,” using AI-guided peptide engineering and nanotechnology to direct therapies precisely to diseased cells while minimizing off-target effects.
Luminary Genetics   
San Jose, USA
Luminary Genetics is a biotech company focused on advanced genetic testing for IVF and reproductive health, using Next Generation Sequencing (NGS) for precision, offering services like PGT-A (Preimplantation Genetic Testing for Aneuploidy) and PGT-SR, aiming to improve success rates for infertile couples by detecting chromosomal issues in embryos for healthier pregnancies.
Lynx Biosciences, Inc.   
San Diego, USA
LynxBio is a biotechnology company developing patient-based ex vivo disease biology and multi-omics platforms to generate data-driven insights into human biology. The company's platform integrates functional testing with multi-omic profiling to study tumor–immune interactions, identify druggable targets and biomarkers, and accelerate the discovery and development of immuno-oncology and immunology therapies.
mAbXell, Inc.   
Redwood City, USA
mAbXell is dedicated to providing reliable and reproducible recombinant antibodies in various forms for diversified applications. They offer a range of services, including the creation of single-chain variable fragment (scFv) libraries, small-scale antibody production for testing, and the design and delivery of custom expression constructs and plasmids.
Magnetic Insight, Inc.   
Alameda, USA
Magnetic Insight is a provider of Magnetic Particle Imaging (MPI) solutions for preclinical imaging. Magnetic Particle Imaging (MPI) is a functional imaging modality similar to PET, SPECT and optical where real time biological events can be monitored verses anatomical imaging such as computed tomography (CT) or magnetic resonance imaging (MRI). MPI offers the ability to target biomarkers, introduced into the cell and as a vascular tracer to support real-time blood flow and vascular architecture...
Mammoth Biosciences, Inc.   
Brisbane, USA
Mammoth Biosciences, Inc. is a privately held biotechnology company specializing in the development of next-generation CRISPR-based therapeutics and molecular diagnostics. The company develops in vivo gene-editing therapies designed as durable, single-course curative treatments. Mammoth's wholly-owned program, MB-111, targets the APOC3 gene to permanently permanently reduce triglyceride levels, aiming to treat severe genetic diseases like Familial Chylomicronemia Syndrome (FCS). The DETECTR®...
Manzanita Pharmaceuticals   
Woodside, USA
Manzanita Pharmaceuticals is a biopharmaceutical company developing a proprietary neurotrophin-based dye/drug platform targeting both surgical imaging and therapeutic applications. Its lead program, NerveLight, is a topically applied intraoperative imaging agent designed to enable fluorescence-guided visualization of nerves during oncologic procedures, initially focused on prostate cancer surgery. By improving nerve identification, NerveLight aims to reduce surgical complications and enhance...
Matrisys Bioscience Inc.   
San Diego, USA
MatriSys BioScience is a clinical-stage pharmaceutical company focused on developing live biotherapeutic products (LBPs) for chronic dermatologic indications. The company's lead clinical development program, MSB-0221 is under development for the treatment of Atopic Dermatitis (AD).
Matrubials, Inc.   
Davis, USA
Matrubials is developing selective antimicrobial therapies to treat bacterial infections, starting with the lead indication bacterial vaginosis. The company mainly focusses on developing antimicrobial peptides from mammalian milk(s) to address bacterial infections, starting with women's health and skin health. Matrubials' AI-enabled technology allows the company to identify and validate bioactive molecules aimed at diverse therapeutics targeting a variety of indications that impact all genders...
Maxterial, Inc.   
Pleasanton, USA
Maxterial is developing non-sticky materials inspired by properties of natural organisms, such as anti-fouling of mussels and self-cleaning of lotus leaves. The company modifies the surface shape or texture of versatile materials through a method that is very affordable and easy to introduce into the existing manufacturing process.
Maze Therapeutics, Inc.   
South San Francisco, USA
Maze Therapeutics is a clinical-stage biopharmaceutical company focused on developing precision small molecule medicines for kidney and metabolic diseases by leveraging insights from human genetics. The company uses the proprietary Compass™ platform, the company identifies and validates disease-driving genetic variants and translates them into targeted drug programs. Its pipeline includes MZE829, a dual-mechanism APOL1 inhibitor in phase 2 development for APOL1-mediated kidney disease (AMKD),...
MedAbome, Inc.   
Fremont, USA
MedAbome, Inc. is a biotechnology company focused on the discovery and development of therapeutic monoclonal antibodies (mAbs) and related biologics for the treatment of oncology and non-oncology diseases. The company has developed a proprietary Live-Cell Immunization (LC-I) and Live-Cell High-Throughput Screening (LC-HTS) platform that enables the identification of antibodies recognizing native and conformational epitopes of disease-specific biomarkers. This approach allows for the generation...
Medalynx   
San Jose, USA
Medalynx is a company that provides a searchable global healthcare data library, integrating genomic, phenotypic, and clinical data from various sources like academic institutions and commercial enterprises. The company's data is used to accelerate research and clinical trial design by providing access to a wide range of medical information.
MedAnswers, Inc   
Washington, USA
MedAnswers is a developer of healthtech applications that connect those struggling to conceive with experts for on-demand questions and answers. The company's application specializes in gathering global clinical specialists that provides answers to all health related questions in the field of diagnostic and testing, fertility medication,treatment planning, reproductive law, embryo screening, surrogacy and pregnancy, enabling infertility patients to make better healthcare decision.
MEDIC Life Sciences   
Mountain View, USA
MEDiC develops proprietary technologies to discover cancer biomarkers, novel drug targets, synthetic-lethal gene interactions, and mechanisms of drug resistance using a unique functional genomics platform. Its approach uses CRISPR integrated with 3D tumor-immune co-culture systems to generate highly translatable data that can guide the development of more effective oncology therapies.
Medikine, Inc.   
San Diego, USA
Medikine is a clinical-stage biopharmaceutical company developing a proprietary PEPTIKINE platform to create engineered peptide mimetics of cytokines for oncology, autoimmune, and infectious diseases. These molecules are designed to be small, low-immunogenic, and easily modified with targeting or other functional features. Its lead candidate, MDK-703, is a Phase 1 IL-7 PEPTIKINE fused to an Fc domain, designed to replicate IL-7 activity and support T-cell maintenance.
Mediphage Bioceuticals, Inc.   
Toronto, Canada
Mediphage Bioceuticals, Inc. is a preclinical-stage biotechnology company, which is developing a next-generation non-viral gene delivery platform based on its proprietary ministring DNA (msDNA) technology. The company uses a proprietary manufacturing platform to develop safe, durable, and redosable gene delivery vectors. msDNA, a versatile platform, is designed to overcome critical challenges facing viral gene therapies and leverage advancements in non-viral gene delivery.
MediPrint Ophthalmics, Inc.   
San Diego, USA
MediPrint™ Ophthalmics (formerly Leo Lens Pharma) is an San Diego-based clinical stage eye care pharmaceutical company focused on helping protect sight by developing and commercializing a proprietary ocular drug delivery portfolio. The company's proprietary MediPrint™ process to develop, clinically test and commercialize drug-eluting, comfort-enhancing contact lenses to treat millions of patients worldwide, without the use of eye drops.
MicrobeDx, Inc.   
Los Angeles, USA
MicrobeDx, Inc. is a molecular diagnostics company developing rapid diagnostic technologies to identify bacteria in clinical specimens and determine their susceptibility or resistance to antibiotics. Its ribosomal RNA (rRNA)-based testing technology and microfluidic disc platform aim to deliver bacterial identification in approximately 30–45 minutes and antibiotic susceptibility results within three hours, helping healthcare professionals select appropriate treatments sooner, reduce unnecessary...
Micronoma   
San Diego, USA
Micronoma is a cancer-detection company using liquid biopsy technology to detect and predict cancer by interrogating the microbial signal with clinical-grade accuracy at an early stage of the disease. The company is focused on developing the minimally invasive microbe-driven liquid biopsy laboratory-developed test (LDT), that uses microbial nucleic acid to help diagnose cancer at early stage. The company's proprietary Oncobiota™ platform is designed to detect cancer early stages (I & II),...
Mindera Health   
Vista, USA
Mindera Health specializes in precision medicine and digital skin analytics within the healthcare sector. The company offers a precision medicine test for psoriasis biologics, utilizing a dermal biomarker patch and transcriptomic data analysis to inform treatment decisions. Mindera Health's technology is designed to assist healthcare providers and payers by delivering individualized genetic information for actionable, data-driven patient care.
Mission Barns   
Berkeley, USA
Mission Barns engages in processing of meat from animal cells, using cellular agriculture to make consumer animal products. The company uses cells from selected animals, grow them in a nutrient-rich environment, and harvest meat.
Moichor   
San Francisco, USA
Moichor is a tech-centered animal diagnostics company. Moichor's mission is to help veterinarians lengthen the lives of their patients by applying deep learning to the diagnostics they use daily. The company's flagship product, Pathview, is an in-clinic hematology and cytology diagnostic system that enables veterinarians to perform advanced laboratory tests directly within their clinics.
Multimeric Biotherapeutics, Inc.   
La Jolla, USA
Multimeric Biotherapeutics, Inc., is a biotechnology company, engaged in the development of proteins for creating vaccines and tumor immunotherapies. The company is focused on applying its CD40L and other TNF SuperFamily ligands for the creation of vaccines to treat human papillomavirus (HPV)-related neoplasms, chronic Hepatitis B virus infection, and other virus infections, and for inducing the immune destruction of tumors while sparing normal tissues.
N1 Life, INC   
Milpitas, USA
​N1 Life develops peptide-based delivery platforms and peptide drug conjugates that improve solubility, enhance penetration, and increase targeted efficacy in skincare and therapeutic applications.
Naked Biome   
San Jose, USA
Naked Biome is a microbiome-based skin therapeutics company, building a drug discovery genomics platform for the treatment of skin diseases and restoration of health. The company's proprietary approach to skin therapy leverages the power of beneficial bacteria on the skin to eliminate harmful bacteria and restore skin to a healthier state.
Nano PharmaSolutions, Inc.   
San Diego, USA
Nano PharmaSolutions, Inc. is a developer of drug delivery technology designed to enhance drug solubility by increasing the surface area of solids. The company's technology helps nano drugs to be made into tablets, capsules, drops, and inhalers and then serve the generic drug industry to improve bioavailability along with nanoformulation development services for emerging pharma companies, enabling pharmaceutical companies to generate nanoparticles of drugs under ultra-low pressure and in situ...
NAVAN Technologies, Inc.   
San Carlos, USA
NAVAN Technologies, Inc. is an enabling technology company commercializing a novel non-viral delivery platform to radically accelerate genetic engineering of human primary cells. The patented NanoStraw technology provides direct intracellular access to hard-to-transfect primary human cells for efficacious delivery of any cargo. By using a physical, non-perturbative mechanism for delivery, the challenges of viral-based cell manufacturing (time, cost and technical difficulties) are eliminated,...
Navega Therapeutics Inc   
San Diego, USA
Navega is a preclinical stage company developing epigenetic-regulation gene therapies to tackle common and complex diseases via a proprietary AI-enabled epigenetic editor platform. Due to the involvement of NaV1.7 in multiple chronic pain states, Navega is harnessing the power of the epigenome to modify its expression and treat multiple chronic pain indications. Other indications in Navega’s pipeline include neurological and inflammatory disorders.
NeuCyte, Inc.   
Mountain View, USA
NeuCyte, Inc. is a biotechnology company specializing in CNS drug discovery using its proprietary SynFire® platform, which employs human iPSC-derived neural cells for disease modeling and drug testing. The company focuses on developing therapies for neurological disorders such as Alzheimer’s, epilepsy, and ALS.
NeuroNascent, Inc.   
Clarksville, USA
NeuroNascent, Inc. is a company developing orally administered small-molecule neuron regenerative therapeutics for age-related neurodegenerative and neurological disorders. The company's product NNI-362, is a patented small-molecule therapy designed to stimulate the formation, maturation and survival of new neurons, with the potential to address neuronal loss associated with Alzheimer’s disease and Parkinson’s disease.
NeuScience   
San Antonio, USA
NeuScience focuses on the discovery of therapeutic treatments for solid tumors by integrating high-throughput biological assays with a proprietary deep-learning platform. The company’s methodology utilizes patient-derived cells combined with specific clinical biomarkers to establish a testing environment designed for predictive accuracy. Their analytical framework employs a deep-learning architecture capable of processing data at single-cell sensitivity, allowing for the identification of...
New Culture Inc.   
San Leandro, USA
New Culture is a startup company making animal-free dairy cheese. The company uses fermentation instead of animals to make dairy proteins with the addition of plant-based fats, sugars and the traditional cheese making process.
Newomics, Inc   
Berkeley, USA
Newomics Inc. is an early stage biotechnology company that commercializes omics platforms and solutions for personalized healthcare. The company's proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS) for analyzing molecules from minute amounts of biospecimens such as blood and urine.The company is also developing a microfluidic device to sort, count, and remove cells based on size from blood (the senescence chip).
NextGen Jane   
Oakland, USA
NextGen Jane is a data-driven women's health company offering a woman insight into her reproductive health through a smart tampon system to track biological changes predictive of disease. The company's tools use a patented tampon collection technology to transform the diverse molecular signals from the endometrium, cervix, fallopian tubes, and ovaries shed during menstruation into digital diagnoses for in-depth sequencing analysis and disease detection, enabling women to send their menstrual...
Niraxx Light Therapeutics Inc.   
Irvine, USA
Niraxx Light Therapeutics Inc is a neurotech company that aims to develop, manufacture, and distribute a new generation of wearable digital therapeutics for brain health that treat depression, anxiety, sexual dysfunction, autism, down syndrome, and somatic pain in a non-pharmaceutical and unprecedented way. The company is planning to integrate AI-empowered, personalized PBM light therapy in the clothing system to provide brain state monitoring, live feedback reporting and real-time light dosage...
Nitrase Therapeutics   
Brisbane, USA
Nitrase Therapeutics is a clinical-stage biopharmaceutical company developing disease-modifying medicines based on its proprietary NITROME™ platform, which targets a newly discovered class of enzymes called nitrases. The company’s lead program, NDC-0524, is a first-in-class antibody designed to selectively target pathogenic nitrated alpha-synuclein to treat Parkinson’s disease. Nitrase is also developing brain-penetrant small-molecule inhibitors of Synuclein Nitrase as a complementary...
Nkarta, Inc.   
South San Francisco, USA
Nkarta, Inc. is a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies. The company's product NKX101 is an allogeneic, cryopreserved, off-the-shelf immune therapy that uses donor-derived natural killer (NK) cells engineered to target NKG2D ligands on cancer cells.
Nodexus Inc.   
San Diego, USA
Nodexus Inc. is a biotech company commercializing the NX-One hardware platform which leverages patented technology from UC Berkeley. The NX-One robustly delivers single cells from biological samples to individual researchers in an easy-to-use manner.
Nvigen, Inc.   
Santa Clara, USA
Nvigen, Inc. is a nanobiotechnology company engaged in the field of multifunctional nanoparticles for biomedical applications. The company's pipeline of solutions stems from the proprietary nanochemistry technology. The company offers customized nanoparticle services and prepackaged nanoparticle reagents for industrial and academic laboratories to research for better imaging, diagnostic, and therapeutic solutions.
OneSkin   
San Francisco, USA
OneSkin is a biotechnology company that believes in the power of data and technology to fight the oldest problem of humanity, aging. OS-01 is a topical supplement of its kind designed to extend skinspan by improving skin health and skin strength. The company's proprietary peptide, OS-01, has been shown to rejuvenate skin on a molecular level and effectively treat the negative implications of aging.
ONK Therapeutics   
San Diego, USA
ONK Therapeutics is dedicated to optimizing next-generation off-the-shelf, optimally engineered NK cell therapies for patients with hematological malignancies and solid tumors. The company’s proprietary NK cell therapy platform is based on a dual-targeted construct, combining a chimeric antigen receptor (CAR) targeting a known tumor antigen with a TRAIL variant targeting the death receptor pathway through DR4 or DR5.
Orb Monitor Ltd.   
London, United Kingdom
Orb Monitor Ltd. focused on real-time microbial monitoring of water, offering solutions to replace traditional, slow, and costly methods. The company provides advanced sensors and a Water Intelligence Platform that leverages AI to deliver actionable insights for water utilities, industries, and commercial buildings. Orb Monitor's technology helps ensure water safety, optimize processes, and promote sustainability by enabling better water management practices.
Orbillion Bio, Inc.   
Fremont, USA
Orbillion Bio, Inc. is an early-stage biotech startup developing cell-based meat technology for a healthy and ethical future of food. The company is a provider of healthy, ethical, and flavorful meats with a complete farm-to-table story to the modern consumer.
Orca Biosystems Inc.   
Menlo Park, USA
Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer and autoimmune diseases. The company's manufacturing platform uses single-cell precision to create proprietary, uniquely-defined products designed to replace a patient’s diseased blood and immune system with a healthy one. The company's lead candidate Orca-T,an investigational allogeneic T-cell immunotherapy being evaluated for the treatment of multiple hematologic malignancies...
Origami Therapeutics, Inc.   
San Diego, USA
Origami Therapeutics is a preclinical-stage biotechnology company developing small-molecule protein degraders and protein conformation correctors for neurodegenerative diseases. The company's proprietary ORICISION™ platform uses patient-derived disease models and computational approaches to identify therapeutics targeting disease-causing proteins, with programs focused on Huntington’s disease, Alzheimer’s disease, Parkinson’s disease, ALS and frontotemporal dementia.
Origin Bioanalytical Laboratory, Inc.   
Rancho Cordova, USA
Origin Bioanalytical Laboratory, Inc. is a provider of bioanalytical laboratory services that support clinical decision-making, enhance the management of laboratory information, and improve patient care. Origin Bioanalytical Laboratory is a contract research organization (CRO) for small molecule LC-MS/MS analysis of pharmaceutical compounds in tissues and biological fluids. The company supports drug development programs from preclinical to late-stage clinical trials.
Palm Therapeutics, Inc.   
San Diego, USA
Palm Therapeutics, Inc. is a biotechnology company whose mission is to develop next-generation therapeutics to treat cancer at the root. The company is leveraging a proprietary technology to develop small molecule depalmitoylating drugs (DPALMs).
Parallel Health, Inc.   
San Francisco, USA
Parallel Health, Inc. is a next-generation skin health company providing targeted solutions utilizing microbiome science, genomics, and machine learning. Parallel operates as a skin telehealth company intended to revolutionize skin and body care by providing deep insights and true personalization. The company's platform aims to help customers understand their skin microbiome and to find the right products through detailed research studies, enabling clients to have full knowledge about their...
Paramune, Inc.   
San Carlos, USA
Paramune Inc. is a California-based biotechnology company. The company focuses on novel molecular mechanisms to treat cancers and autoimmune diseases more effectively.
Particella, Inc.   
San Francisco, USA
Particella, Inc. is an early-stage preclinical biotechnology company focused on developing next-generation category of medicines. The company's proprietary vector technology is used to design oral and non-immunogenic medicines, and to carry mRNA and other nucleic acids to the GI cells to fight intestinal and systemic diseases, and also modifies the GI tract to restore its abilities in patients with genetic diseases or with compromised mucosa.
PassPort Technologies, Inc.   
San Diego, USA
PassPort Technologies Inc. is a biotechnology company focused on the development of advanced drug delivery systems. The company is dedicated to advancing research and development efforts toward the commercialization of its proprietary PassPort® Microporation Technology, a needle-free transdermal delivery platform designed to enhance the delivery of therapeutics, biologics, peptides, and vaccines through the skin.
Pathways to Stem Cell Science   
Torrance, USA
Pathways to Stem Cell Science is a non-profit institute and provider of real-world training in molecular cell biology, stem cell biology and regenerative medicine.
Persephone Biosciences   
San Diego, USA
Persephone Biosciences Inc. is a biotechnology company that leverages real-world data and artificial intelligence to design microbiome therapeutics and diagnostics to promote normal immune function and fight diseases. Persephone Biosciences leverages the systemic impact of the gut microbiome on the human immune system. Persephone's technology platform is based on clinical trials, advanced genomics and immunology techniques, and machine learning to understand the impact of gut microbes on patient...
Phanes Therapeutics, Inc.   
San Diego, USA
Phanes Therapeutics, Inc. is a biotechnology company focused on the research, discovery, and early-stage development of therapeutic agents within the field of immuno-oncology. The company operates through the application of proprietary technology platforms, specifically PACbody®, SPECpair®, and ATACCbody®, to engineer native IgG-like bispecific antibodies. These platforms are designed to address challenges in antibody development by focusing on properties such as manufacturability, drug-like...
Pheronym, Inc.   
Woodland, USA
Pheronym is an agricultural biotechnology company developing nontoxic solutions for plant protection. The company specializes in the development and manufacture of pheromones that direct nematodes towards insects and away from plants.
Phyla   
San Francisco, USA
Phyla is developing a platform technology to enhance natural phage with payloads to improve bacterial targeting and neutralization. Instead of antibiotics’ strategy of killing all bacteria which results in drug resistance and frequent relapses, Phi’s approach is to kill only “bad” bacteria, resulting in less resistance and better long-term outcomes.
Pinpoint Science, Inc.   
San Francisco, USA
Pinpoint Science, Inc. is developing bioelectronic point-of-care diagnostics for viral, bacterial and fungal pathogens. The company's nanosensors are used to detect biomarkers, antibodies, antigens, toxins, nucleic acids to identify specific microbial pathogens.
Pivot Bio, Inc.   
Berkeley, USA
Pivot Bio, Inc. is a biotechnology company that develops novel agricultural fertilizers using microbes from the crop microbiome. The company's focus is on creating microbes that associate with corn and produce renewable nitrogen for the plant, reducing the need for synthetic fertilizers. By harnessing the power of the crop microbiome, Pivot Bio aims to improve crop yields and promote sustainable agriculture practices.
Plex Pharmaceuticals, Inc.   
San Diego, USA
Plex Pharmaceuticals is a scientifically-driven company with a vision to improve the lives of patients diagnosed with complex, degenerative diseases. The company is focused on the treatment of diseases generally caused by protein mis-folding such as ALS, Parkinson's Disease and cataracts.
Polaris Genomics   
Gaithersburg, USA
Polaris Genomics is a privately held biotechnology company specializes in AI-powered genomics and precision neuropsychiatry, developing molecular biomarkers, objective diagnostics, and therapeutic discovery tools for mental health and neuropsychiatric disorders. Its proprietary ADAPT™ Neuropsychiatric Biomarker Discovery Platform integrates next-generation sequencing, transcriptomics, and machine learning to identify blood-based RNA biomarkers associated with conditions including post-traumatic...
polySpectra, Inc   
Berkeley, USA
polySpectra is an advanced materials company that helps innovative engineers 3D print end-use components that they can trust, using the world’s most rugged photopolymer resins. The company uses a modular chemical platform to develop additive polymers with a wide range of specific properties. The company product COR Alpha is a tough, heat-resistant resin known for its durability and very low moisture absorption. The company's another product COR Black, an industrial-grade variant optimized...
Pomodyne, Inc.   
Menlo Park, USA
Pomodyne, Inc. focuses on developing smart crop cultivation technology to revolutionize the production of fruit crops. Utilizing plant biotechnology and controlled environment agriculture, Pomodyne's core mission is to address challenges like climate change, food safety, and food security by transforming traditional agriculture methods. The company is developing innovative technology that aims to grow fruits without the fruit plant, which could potentially deliver out-of-season fruits sustainably....
Pow.bio   
Pow Genetic Solutions, Inc.
Berkeley, USA
Pow.bio provides intelligent fermentation services for industrial and synthetic biology, helping turn ideas into profitable products. The company's services combine continuous fermentation with control methodology to quickly optimize the fermentation process and deliver better yields. Pow.bio's technology offers bioreactor-agnostic hardware, real-time AI process control, and stable long-run fermentation capabilities, enabling biotech, food, and industrial producers to lower production costs,...
PreciGenome LLC   
San Jose, USA
PreciGenome is a developer of a nanoparticle synthesis system and analytical instrument designed to help the healthcare industry. The company focuses on developing microfluidic bio-platforms for customers in applications such as PCR systems and kits, nanoparticle synthesis systems, single-cell, droplet generators, and the integrated flow iFlow microfluidic controllers, enabling the healthcare industry to make quality diagnostics.
Predicine, Inc.   
Hayward, USA
Predicine is a molecular insight company developing genomic profiling tests and robust algorithms for cancer diagnostics and monitoring. The company's biology-oriented approach to analyzing genomics is advancing the understanding of tumor mutational landscape.
Prellis Biologics   
Berkeley, USA
Prellis Biologics is a developer of a bioprinting technology designed to recreate and engineer human tissues in vitro. The company's technology precisely reproduces the human immune response through the creation of lymph node organoids and can exploit fully human immune responses for a variety of applications, including antibody discovery, immunogenicity assessment, and tumor-immune models, improving patients' lives by addressing challenges commonly faced in early-stage drug discovery and translational...
Primmune Therapeutics, Inc.   
Carlsbad, USA
Primmune Therapeutics is a clinical-stage biotech harnessing the power of the innate immune system for therapeutic benefit through development of novel small molecule, orally administered toll-like receptor 7 (TLR7) agonists. The company's product PRTX007 is a clinical-stage novel oral small molecule that specifically activates toll-like receptor 7 (TLR7), which drives the innate immune system’s primary response to viral infections, enabling broad spectrum antiviral activity.
ProLynx Inc   
Emeryville, USA
ProLynx Inc. focuses on developing innovative long-acting drug delivery technologies and therapeutics. The company uses its proprietary technology to extend the duration of drug activity, particularly for peptides, proteins, and small-molecule medicines. The research and development activities target therapeutic areas including oncology, obesity, and metabolic diseases, with the goal of reducing dosing frequency and improving patient convenience and treatment outcomes.
Prominex Inc.   
San Diego, USA
Prominex Inc.is focused on developing near-patient testing with rapid, central lab accuracy for clinically actionable results and cost-effective testing kits for broad accessibility. The company's Prominex system is a transformative molecular diagnostic testing solution for near patient care settings designed to deliver results in 5 minutes. The novel molecular amplification and detection technologies enables the development of molecular diagnostic assays.
Protillion Biosciences   
Carlsbad, USA
Protillion Biosciences is a developer of a high-throughput protein engineering platform designed to discover the next generation of antibody drugs. The company has developed a novel, powerful, and high-throughput protein display platform designed to revolutionize traditional approaches to the design and development of protein-based drugs, enabling healthcare professionals to accelerate the discovery and development of new protein therapeutics.
protocols.io.   
Berkeley, USA
protocols.io is a secure platform for developing and sharing reproducible methods. The company's platform enables scientists to make, exchange, improve, and discuss protocols. They aim to accelerate research by increasing collaboration and sharing among researchers, while improving efficiency.
Provenance Biofabrics   
San Francisco, USA
Provenance Bio is a biotechnology company focused on creating animal-free collagen using advanced protein and synthetic biology approaches. Their mission is to support a more sustainable and compassionate future by producing complex proteins without the need for animals.
PTM Therapeutics   
San Carlos, USA
PTM Therapeutics creates and develops therapies for the treatment of chronic diseases and cancer. The company's lead product PTM-001 is a humanized glycan targeting antibody that is being developed for the treatment of Inflammatory Bowel Disease/UC.
PuraCath Medical, Inc.   
Newark, USA
PuraCath Medical, Inc. is dedicated for the dialysis patient by reducing infections related to peritoneal dialysis (PD) and through simplified connection of PD catheters. The FireflyTM catheter connection system is a UV-enabled disinfection technology designed to minimize user compliance.
Quadriga BioSciences, Inc.   
Los Altos, USA
Quadriga BioSciences is a clinical-stage oncology company developing QBS72S (formerly QBS10072S), a small-molecule chemotherapeutic agent for the targeted treatment of cancer. QBS72S uses the L-type amino acid transporter 1 (LAT1) to cross the blood-brain barrier and enter cancer cells, where it induces DNA damage leading to cell death. The company is developing QBS72S for brain malignancies and other cancers with elevated LAT1 expression.
QuantumCyte, Inc   
Fremont, USA
QuantumCyte, Inc. is a privately held biotechnology company focused on developing automated tissue microdissection technologies for molecular diagnostics and precision medicine. The company's proprietary NextGen Microdissection platform enables the precise identification, enrichment, and extraction of DNA, RNA, and proteins from targeted cells within tissue specimens, including formalin-fixed paraffin-embedded (FFPE) and frozen tissue sections. By isolating clinically relevant cell populations,...
R2M Pharma Inc.   
South San Francisco, USA
R2M Pharma is a biotechnology company devoted to the discovery of small molecules preclinical development compounds for the treatment of unmet medical indications.
R3 Vascular Inc.   
Mountain View, USA
R3 Vascular Inc. is a privately held, venture-backed medical device company that develops next-generation bioresorbable vascular scaffolds (BVS) for treating peripheral artery disease (PAD). The company's proprietary platform most notably its MAGNITUDE® drug-eluting scaffold combines the structural support of a traditional metallic stent with a sirolimus coating designed to minimize local blood vessel inflammation. Unlike permanent metal implants, R3 Vascular's ultra-thin polylactic acid polymer...
Raydiant Oximetry, Inc.   
San Ramon, USA
Raydiant Oximetry is a company developing a fetal monitoring device. The company offers a non-invasive biomedical device to monitor the oxygen levels in fetal blood during childbirth. The device is designed to help clinicians reduce the risk of birth injury and over-intervention as well as decrease cesarean delivery rates.
Reactive Medical Labs Inc.   
Davis, USA
Reactive Medical Labs is a biotechnology company developing regenerative skincare applications. The company aims to improve the penetration of agents across the skin barrier for common and visible skin conditions. The company develops proprietary topical aesthetic and therapeutic prescription-strength skin care systems to isolate pure and potent MSC-derivedExosomes, enabling healthcare institutions to solve the unmet needs of skincare aging.
Regel Therapeutics Inc.   
Cambridge, USA
Regel Therapeutics develops precision genetic medicines for severe genetic diseases using a proprietary Targeted EpiEditing platform. The technology combines a deactivated version of CRISPR-Cas9 fused with an epigenetic modulator to correct abnormal gene expression without altering the underlying DNA sequence. Interventions are delivered via adeno-associated virus (AAV) vectors equipped with proprietary regulatory elements designed to restrict therapeutic activity exclusively to the specific...
Regencor, Inc.   
San Carlos, USA
Regencor is a regenerative medicine company dedicated to developing cardiac regenerative therapies aimed at treating myocardial infarction and heart failure. The company is advancing two distinct formulations of its proprietary active pharmaceutical ingredient (API), non-glycosylated rhFSTL1, to facilitate the direct delivery of this regenerative protein to the human heart during Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG) procedures.
Regenerative Arthritis & Bone Medicine, Inc.   
Burlingame, USA
Regenerative Arthritis & Bone Medicine, Inc. (RABOME) is a biotechnology research and development company focused on advancing innovative therapies for musculoskeletal diseases and bone regeneration. The company is developing novel treatments for conditions such as osteonecrosis, fracture healing, osteoporosis, and inflammatory arthritis. Its lead therapeutic candidate, RAB-001 (LLP2A-Ale), is designed to enhance bone repair by targeting mesenchymal stem cells (MSCs) to bone surfaces through...
Rejuvenation Technologies Inc.   
Mountain View, USA
Rejuvenation Technologies Inc. is a developer of a telomere extender designed to reverse the effect of telomere shortening. The company's nucleoside-modified mRNA encodes telomerase reverse transcriptase which is delivered to cells to transiently increase telomerase activity for extending telomeres which increase the proliferative capacity of cells, enabling patients to slow down age-related diseases and conditions. The company's current disease areas are pulmonary fibrosis (COPD), liver cirrhosis,...
Resilient Biotics, Inc   
Durham, USA
Reslient Biotics is a company developing microbiome-based live biotherapeutics for respiratory diseases in animal and human health. The company uses proprietary microbiome genomics, machine learning, data analytics and targeted laboratory assays to identify naturally occurring microbial strains with pathogen-inhibiting and immune-activating properties. The company's development programs focus on non-antibiotic approaches to prevent or reduce complex respiratory infections, including bovine and...
Revel Pharmaceuticals, Inc.   
San Francisco, USA
Revel Pharmaceuticals develops targeted therapeutic enzymes to clear molecular damage in the extracellular matrix (ECM). By targeting advanced glycation end-products (AGEs) like glucosepane crosslinks, their platform aims to restore tissue elasticity, lower blood pressure, and reverse age-related ECM stiffening.
Riboscience LLC   
Palo Alto, USA
Riboscience LLC's mission is to imagine, design, and research novel ribose-based molecules that have the potential to revolutionize drugs that target human cancers and viral diseases.
Rize Oncology Inc.   
San Lorenzo, USA
ize Oncology Inc. formerly GeneTether Therapeutics Inc., renamed in January 2025. They are focused on developing precision medicines for cancer treatment, particularly soft tissue sarcoma. The firm focuses on advancing its lead small-molecule drug candidate, STS-201, for treating soft tissue sarcomas and other cancers.
Rubedo Life Sciences, Inc   
Sunnyvale, USA
Rubedo Life Sciences is a biopharmaceutical company developing a broad portfolio of therapies engineered to target cells which drive chronic age-related diseases. The company's product RLS-1496 is a first-in-class disease-altering GPX4 modulator selectively targeting pathological senescent cells that drive inflammaging and chronic degenerative diseases and conditions associated with the biological aging process. The company's another product RBO-2XX is under development for Respiratory disease.
Rubik Therapeutics   
Cambridge, USA
Rubik Therapeutics is a biotechnology company developing advanced cell therapies for solid tumors, utilizing a computational platform to identify unique tumor targets and a proprietary engine to overcome immune suppression. The company is a developer of oncology therapeutics designed to leverage a proprietary portfolio of truly selective cancer targets. Rubik Therapeutics offers leveraging immune cell signaling to counteract immune suppression, enabling people to get safer and more effective...
RUMI Scientific   
Brooklyn, USA
RUMI Scientific drugs are discovered through its proprietary human stem cell technology that uses single-cell, time-lapse imaging, and customized analytic tools to identify treatments for human genetic diseases. The company designed small molecule based drugs to treat genetic diseases with focus on Huntington's Disease. The company's leading program involves an oral bromodomain-containing protein 9 (BRD9) inhibitor used for treating Huntington's disease.
SafeBVM Corp   
Boston, USA
SafeBVM™ mission is to prevent patient harm during manual ventilation. SafeBVM™ develops the Sotair® product family to bring consistency and safety to both clinical care and training. The company's product Sotair is a small, lightweight, easy-to-use flow control valve that fits between a manual resuscitator and a patient mask or airway. The company's another product SotairIQ is a research-backed, station-based training platform designed to improve manual ventilation by focusing on the...
Sciogen LLC   
San Jose, USA
Sciogen is a preclinical stage biotech company focused on developing novel vaccines and therapeutic antibodies against influenza and respiratory syncytial viruses. The company develops a quadrivalent flu vaccine (EC-QIV), a pre-pandemic monovalent vaccine (EC-PIV), and cross-neutralizing monoclonal antibodies (HC-imAb).
Scout   
Santa Clara, USA
Scout is developing diagnostic tests through Loop-de-LoopTM platform which enables simplicity, speed, and lower costs while providing accurate, lab-grade results.The company focuses on expanding testing capabilities at underserved point of care facilities and introducing access to lab-grade diagnostic tests to people at home, schools, or offices.
Shasqi, Inc.   
San Francisco, USA
Shasqi, Inc. is a privately held company focused on developing cancer treatments using bioorthogonal “click” chemistry for localized drug delivery. The company’s lead program, SQ3370, is in clinical testing and pairs an intratumoral biopolymer activator with a doxorubicin protodrug, enabling delivery of much higher effective doses with improved tolerability. Beyond this, Shasqi’s preclinical pipeline includes antigen-targeted activators against HER2, TROP2, Nectin-4, and CEACAM5, linked...
Shiru   
Berkeley, USA
Shiru is a computational biology company. The company produces novel, functional proteins for food applications leveraging molecular design. The company goal is to make ingredients that decrease the reliance on animals for food by providing alternatives that are more sustainable and nutritious.
Siege Pharmaceuticals   
Irvine, USA
Siege Pharmaceuticals is a California-based company focused on developing cancer therapeutics targeting pathways involved in cellular growth. The company's drugs are synthetic variants with optimized drug-like properties that target multiple pathways that cancer cells need for growth thereby inhibiting those cells from developing resistance, enabling medical practitioners to control the growth of cancer cells and prevent them from developing further.
SimplSeq, Inc.   
Murrieta, USA
simplSEQ has created a patented process for the purification, preservation and analysis of any genomic material. The company applied a Six Signa mentality to the science focusing on building quality upfront and eliminating error-prone steps.
Sinopia Biosciences Inc.   
San Diego, USA
Sinopia Biosciences, Inc. is a privately held biotechnology company advancing novel therapeutics using its proprietary LEADS® (LEarn And DiScover) drug discovery platform. Sinopia’s LEADS® platform combines high-throughput omics data, AI/machine learning, and network analyses. Sinopia is actively pursuing multiple first-in-class programs with high unmet need including its lead program for Parkinson’s disease.
Siolta Therapeutics   
San Carlos, USA
Siolta Therapeutics is a clinical-stage biopharmaceutical company leveraging human microbiome data to prevent and treat chronic inflammatory and atopic diseases. The company's Precision Symbiotics Platform™ utilizes machine learning and network analysis to identify synergistic microbial candidates from high-resolution clinical data. These findings are then refined through a proprietary biobank and advanced anaerobic manufacturing to create rationally designed, pharmaceutical-grade live biotherapeutic...
Sira Medical   
San Francisco, USA
Sira Medical is the developer of an augmented reality software app RadHA (Radiology with Holographic Augmentation) that allows surgeons to project 3D radiology images onto a real-world background. The company's software allows clinicians to display 3D radiology images onto real-world backgrounds to educate patients about their surgeries, enabling healthcare professionals to understand complicated anatomy before surgery, view and project it in a new way, and make the surgical procedure faster,...
Skoruz Life Sciences LLC   
Newark, USA
Skoruz Life Sciences is a research organization focused on early discovery and preventive care by bringing together human genetic analysis and cognitive technologies. The company is active in novel diagnostics that aimed at creating rapid response diagnostics frameworks by learning healthcare systems creating continually improving early interventions based on data insights.
Solarea Bio, Inc.   
Waltham, USA
Solarea Bio, Inc. is a developer of microbiome-based therapeutics designed to improve human health. The company uses microbial discovery and genomics to prevent the onset or progression of health problems associated with chronic inflammation, enabling hospitals to provide medicinal drugs for improved quality of life.
Solvexa, LLC   
San Diego, USA
Solvexa is a company focused on developing of paradigm-shifting technologies for life and physical sciences. The company's core activities revolve around innovation and development in areas such as chiral separations and GPCR (G Protein-Coupled Receptor) drug discovery.
Spinogenix, Inc.   
Los Angeles, USA
Spinogenix, Inc. is a privately-held, preclinical-stage pharmaceutical company developing therapies aimed at increasing synapses and restoring neural connections affected by neurodegenerative diseases. The company's small molecules are intended to restore synapse levels to address memory loss and cognitive decline. The firm's lead drug candidate, SPG302, operates by stimulating synapse production and is currently being studied for the treatment of neurodegenerative and neuropsychiatric disorders....
Stem Pharm Incorporated   
Madison, USA
Stem Pharm Incorporated is a supplier of synthetic biomaterials that are specifically designed to meet customer's requirements and develops more advanced cellular models for drug discovery and toxicity screening and cellular therapies for regenerative medicine applications. The company's synthetic biomaterials support the optimization of cell expansion and differentiation, human tissue formation and cell/tissue delivery applications.
Stemson Therapeutics Corporation   
San Diego, USA
Stemson Therapeutics is a pre-clinical stage cell therapy company leveraging the regenerative power of induced pluripotent stem cells (iPSC) to cure hair loss. The company uses the iPSC-derived cells to grow de novo hair follicles.
Sunomix Therapeutics   
San Diego, USA
Sunomix Therapeutics is a biotechnology company developing novel vaccines and therapeutics using mRNA, nanoparticle, antibody, and protein-based technologies. Its technology portfolio includes mRNA-LPN delivery systems, therapeutic antibodies, antibody-drug conjugate (ADC) nanoparticles, virus-like particles (VLPs), self-assembling protein nanoparticles, and genetic vectors. The company’s programs target infectious diseases and cancer, including experimental vaccines and targeted cancer therapies....
Syntr Health Technologies, Inc.   
Irvine, USA
Syntr Health Technologies Inc. is a medical device company, targeting the reduction of diabetic foot amputations in the aging population using the patients own fat.
Tag.bio   
San Francisco, USA
Tag.bio, enables organizations to securely derive insights using data-as-products in a data mesh architecture. Customers use Tag.bio’s data science platform to discover, share, and unite diverse siloed data sets and execute workloads using no-code/low-code data mesh framework. The data science platform (available in AWS and Azure Marketplaces) combines data sets, smart APIs, statistical and machine learning algorithms into data products (application layer) for users to discover insights via...
TB-Seq, Inc.   
South San Francisco, USA
TB-Seq provides experimental and computational services in cutting-edge RNA sequencing technology, consulting, design, and execution of customized experimental and computational procedures. The company develops applications for experimental and computational procedures for functional (meta)genomics analysis of prokaryotic and eukaryotic organisms and communities based on the ribosome profiling NGS platform technology (RIBO-seq) and on computational analysis of sequencing data.
Tegmine Therapeutics   
San Francisco, USA
Tegmine Therapeutics is a biotechnology that develops antibody-based therapeutics for cancer by targeting tumor-specific glycoproteins. The company has engineered a system to generate revolutionary new antibody-based therapies for cancer which dramatically increase efficacy while reducing toxic side effects. The company's TegMiner™ platform enables the discovery of unique cancer epitopes and allows to develop these life-changing new antibodies for patients with unmet needs.
Telo Therapeutics, Inc.   
San Francisco, USA
Telo Therapeutics, Inc. is a developer of cancer therapeutics designed to treat TERT promoter (TERTp) mutant cancers. The company's platform leverages a novel precision medicine approach to inhibit cancer cell immortality by targeting an enzyme called telomerase used by cancer cells in the immortalization process, enabling the medical community and patients to improve associated treatment outcomes.
Tibi Health Inc.   
San Francisco, USA
Tibi Health Inc. is an early-stage digital health technology company that develops AI-powered solutions to assess, predict, and help prevent mental health conditions, particularly depression and anxiety. The company focuses on supporting parents during fertility, pregnancy, and the postpartum period through health data analysis, predictive algorithms, and digital technologies.
TIGAR Health, Inc.   
Moraga, USA
TIGAR Health delivers a personalized medicine solution to provide more effective treatment of Type 2 diabetes and prediabetes. TIGAR reduces the complexity of choosing the right drugs by eliminating the trial-and-error method used today.
Toray International America Inc. (TIAM)   
New York, USA
Toray International America Inc. (TIAM) imports and exports the products of Toray Group companies throughout the Americas.
Transeo Radiotherapy Solutions LLC   
San Francisco, USA
Transeo Radiotherapy Solutions LLC is engaged in the development and maintenance of a web-based medical software suite. The company offers Vantage, a web‑enabled software suite designed to optimize operations at radiotherapy treatment centers
TrueBinding Inc.   
Santa Clara, USA
TrueBinding Inc. is a pioneering clinical-stage biotherapeutic company at the forefront of creating groundbreaking molecules to address a wide spectrum of challenging medical conditions. The company's products TB006 is a humanized monoclonal antibody that targets Galectin-3 to treat Alzheimer's disease (AD).
Tulavi Therapeutics   
Los Gatos, USA
Tulavi Therapeutics is a privately held medical device company with a mission to transform peripheral nerve surgery through biomaterial solutions. The company's proprietary in situ forming hydrogel technology represents a breakthrough approach to nerve repair and protection, addressing critical unmet needs in peripheral nerve surgical procedures. Tulavi is committed to advancing patient outcomes and improving the standard of care for surgeons treating peripheral nerve conditions.
TumorGen, Inc.   
San Diego, USA
TumorGen is developing a novel drug discovery platform to identify unseen therapeutic targets associated with cancer metastasis. The company's first-in-class drug discovery pipeline for true anti-metastatic drugs is powered by TumorGen's proprietary discovery engine.
Unite Genomics, Inc.   
San Mateo, USA
Unite Genomics is a U.S.-based health technology company that develops an AI-powered platform for integrating and analyzing patient health data to accelerate medical research and improve treatment access. The platform connects with thousands of healthcare systems and electronic health record (EHR) databases to unify patient medical records, enabling researchers, pharmaceutical companies, and healthcare providers to gain deeper insights into patient journeys and care pathways.
Upside Foods   
Berkeley, USA
UPSIDE Foods produces meat directly from animal cells without the need to raise and slaughter animals. The company's products include hot dogs, sausages, burgers, and meatballs. Producing cell-based meat generates less waste and dramatically fewer greenhouse gas emissions than traditional animal farming.
Valitor Inc.   
Berkeley, USA
Valitor, Inc. is a biotechnology company developing long-acting biologic therapies for ophthalmic diseases using its proprietary Multivalent Polymer (MVP) technology platform. The company's lead product candidate, VLTR-559, is a long-acting anti-VEGF biologic in IND-enabling development for the treatment of wet age-related macular degeneration (AMD).
Valley Fever Solutions, Inc.   
Tucson, USA
Valley Fever Solutions, Inc. is a clinical-stage biotechnology company dedicated to developing therapies for Valley Fever, a serious fungal disease with limited treatment options. The company's primary asset is Nikkomycin Z, an investigational antifungal with a novel mechanism of action targeting fungal chitin synthesis. Its lead program aims to provide a more effective and potentially curative treatment than existing antifungal drugs. Valley Fever Solutions is initially focused on treating...
Venture Valuation VV AG   
Zurich, Switzerland
Venture Valuation AG specializes in independent assessments and valuations of companies in high-growth markets, such as biotechnology, life sciences and medical technology. Valuations are provided for fundraising, investment decision, portfolio valuations, in- and out-licensing and M&A. The company has developed "Biotechgate", which is business development and licensing database for the life sciences industry.
Verge Labs   
South San Francisco, USA
Verge Labs develops AI models trained on proprietary multimodal human tissue data to power target discovery, in-silico validation, patient stratification, indication prioritization, and biomarker prediction. Verge partners with pharmaceutical and biotech companies to accelerate the development of treatments for CNS diseases and other complex human conditions.
VeriSkin, Inc.   
San Diego, USA
Veriskin is a medical device company dedicated to facilitating and improving the accuracy of skin cancer screening. Veriskin has developed a non-invasive hand-held device to rapidly and objectively determine whether a suspect skin lesion is cancerous. The company's device determines if a suspect skin growth is cancerous and also comes at a low cost that comes up with a non-subjective assessment of suspect skin regions by non-specialist frontline caregivers, enabling caregivers to detect cancer...
Verrica Pharmaceuticals Inc.   
West Chester, USA
Verrica is a dermatology therapeutics company. The company is committed to the development and commercialization of novel treatments that provide significant benefit for people living with skin diseases. The company's product VP-102 is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin (0.7% w/v) delivered via a single-use applicator that allows for precise topical dosing and targeted administration.
ViCardia Therapeutics Inc.   
San Francisco, USA
ViCardia Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for treating heart failure (HF) involving mitochondrial dysfunction. The company’s lead compound, GP531, is a potent, orally active, second-generation adenosine regulating agent, that targets mitochondrial dysfunction, reversing the decline in the production of cellular energy in the form of adenosine triphosphate (ATP), and improving cardiac function....
ViQi, Inc.   
Santa Barbara, USA
ViQi AI is a specialized software-as-a-service (SaaS) platform designed to provide AI-powered image analysis and data management solutions for the life sciences and drug discovery sectors. The company focuses on automating complex biological workflows, particularly in the areas of high-content screening and digital pathology.
ViroMissile, Inc.   
San Diego, USA
ViroMissile is an oncology-focused biotechnology company that develops engineered oncolytic viral therapies designed for intravenous delivery. The company centers the research and clinical candidates around the company's proprietary Intravenously Deliverable Oncolytic Virus (IDOV) platform, which uses modified vaccinia virus vectors engineered to survive bloodstream clearance, selectively target and replicate within tumor cells, and stimulate anti-tumor immune responses in solid tumors.
Viscient Biosciences   
San Diego, USA
Viscient Biosciences is a biotechnology company focused on transforming drug discovery by replacing traditional animal models with highly predictive 3D human tissue models. Its platform combines bioprinted human tissues with advanced molecular analysis to better understand disease biology, identify novel drug targets, and develop new therapeutics. The company initially concentrates on metabolic liver diseases, particularly metabolic dysfunction-associated steatotic liver disease (MASLD/NAFLD)...
Visolis, Inc.   
Hayward, USA
Visolis Inc, a bioengineering company, develops carbon-negative and sustainable chemicals for consumers and the chemical industry. The company's systems approach integrates innovations in synthetic biology, chemical catalysis, and process scale-up to enable new bio-based manufacturing platforms.
Vivreon Biosciences   
San Diego, USA
Vivreon Biosciences is developing a new class of small molecule therapeutics for the treatment of chronic diseases. The company is focusing on Inflammatory bowel diseases (IBD) and Neurodegenerative diseases.
X-Therma Inc.   
Hercules, USA
X-Therma Inc. is a biotechnology company developing technology for regenerative medicine and organ preservation. The company's flagship product XT-Thrive®, a DMSO-, Serum-, Protein-free and chemically defined cryopreservation solution directly plugs into the current CMC workflow, resolves bottlenecks in the cell manufacturing process, and enables “off-the-shelf” living medicines.
XCellAssay   
Berkeley, USA
XCellAssay, Inc. is a U.S.-based biotechnology company developing cell-based bioassay technologies for detecting biologically active chemical contaminants in drinking water. The company uses engineered cell lines and multiplexed bioassays to identify chemicals, including endocrine-disrupting compounds, that may not be captured by conventional water quality testing, providing testing services for consumers and supporting environmental monitoring applications.
Xosomix, LLC   
San Diego, USA
Xosomix, LLC is a biotechnology company involved in the development of the next generation therapeutics using exosomes. The company is founded on the preclinical research demonstrating the first therapeutic use of exosomes in a brain disorder, Rett Syndrome.
XPose Therapeutics   
San Francisco, USA
XPose Therapeutics is an early stage drug discovery company leveraging a cutting-edge approach using experimental information on 3D protein-ligand interactions as a starting point to discover and develop target-specific small molecule cancer therapeutics for traditionally “undruggable” targets.
Yuzu Labs Public Benefit Corporation   
San Jose, USA
Yuzu Labs PBC is a software company that creates digital solutions for clinical research and healthcare. One of its main products is StudyPages, a platform designed to support and simplify the clinical research process. Yuzu Labs builds software to help make research more accessible and integrated into everyday life.
ZabBio Inc.   
San Diego, USA
ZabBio Inc. is a privately held biotechnology company. The company is focused on developing monoclonal antibody-based therapeutics to treat infectious diseases and provide nonhormonal reproductive health solutions. ZB-06 is an on-demand, non-hormonal, and non-surfactant vaginal contraceptive film developed by ZabBio. It contains an engineered human contraceptive antibody (HC4-N) that potently agglutinates and inactivates sperm.
Ziteo Medical, Inc.   
Berkeley, USA
Ziteo Medical, Inc. is engaged in the development of cancer detection systems intended to improve the diagnosis of cancer treatment. The company is developing a portable and robotic medical imaging system that allows the imaging, localization, and treatment of tumors early, enabling patients with proper treatments for cancer disease.
ZoneOne Pharma, Inc.   
San Francisco, USA
ZoneOne Pharma, Inc. is developing next-generation liposomal technologies and nanomedicines to treat chronic disorders. The company offers a broad range of formulation expertise to identify and test the optimal drug delivery choice for therapeutics.
Zuno Medical   
Campbell, USA
Zuno Medical provides sterilization solutions for hospitals and surgical centers. The company offers Internet of things device that integrates sensors, electromechanics, and algorithms for sterilization applications.

Disclaimer: Any membership totals displayed reflect organizations who have agreed to display their membership information and may not be indicative of CLSA's total member population.

© Biotechgate by Venture Valuation